<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Bioeng Biotechnol</journal-id><journal-id journal-id-type="iso-abbrev">Front Bioeng Biotechnol</journal-id><journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id><journal-title-group><journal-title>Frontiers in Bioengineering and Biotechnology</journal-title></journal-title-group><issn pub-type="epub">2296-4185</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12098461</article-id><article-id pub-id-type="publisher-id">1446537</article-id><article-id pub-id-type="doi">10.3389/fbioe.2025.1446537</article-id><article-categories><subj-group subj-group-type="heading"><subject>Bioengineering and Biotechnology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Natural bioactive compounds modified with mesenchymal stem cells: new hope for regenerative medicine</article-title><alt-title alt-title-type="left-running-head">Wu et al.</alt-title><alt-title alt-title-type="right-running-head">
<ext-link xlink:href="https://doi.org/10.3389/fbioe.2025.1446537" ext-link-type="uri">10.3389/fbioe.2025.1446537</ext-link>
</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Jingjing</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Ge</surname><given-names>Ying</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Wendi</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/912312/overview"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Li</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Huang</surname><given-names>Juan</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="c001" ref-type="corresp">*</xref><uri xlink:href="https://loop.frontiersin.org/people/749848/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Huang</surname><given-names>Nanqu</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="c001" ref-type="corresp">*</xref><uri xlink:href="https://loop.frontiersin.org/people/836533/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Luo</surname><given-names>Yong</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="c001" ref-type="corresp">*</xref><uri xlink:href="https://loop.frontiersin.org/people/1202329/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Department of Neurology</institution>, <institution>Third Affiliated Hospital of Zunyi Medical University (The First People&#x02019;s Hospital of Zunyi)</institution>, <addr-line>Zunyi</addr-line>, <addr-line>Guizhou</addr-line>, <country>China</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Key Laboratory of Basic Pharmacology and Joint International Research Laboratory of Ethnomedicine of Ministry of Education</institution>, <institution>Zunyi Medical University</institution>, <addr-line>Zunyi</addr-line>, <addr-line>Guizhou</addr-line>, <country>China</country>
</aff><aff id="aff3">
<sup>3</sup>
<institution>National Drug Clinical Trial Institution</institution>, <institution>Third Affiliated Hospital of Zunyi Medical University (The First People&#x02019;s Hospital of Zunyi)</institution>, <addr-line>Zunyi</addr-line>, <addr-line>Guizhou</addr-line>, <country>China</country>
</aff><aff id="aff4">
<sup>4</sup>
<institution>Department of Gerontology</institution>, <institution>Third Affiliated Hospital of Zunyi Medical University (The First People&#x02019;s Hospital of Zunyi)</institution>, <addr-line>Zunyi</addr-line>, <addr-line>Guizhou</addr-line>, <country>China</country>
</aff><author-notes><fn fn-type="edited-by"><p>
<bold>Edited by:</bold>
<ext-link xlink:href="https://loop.frontiersin.org/people/42215/overview" ext-link-type="uri">Basem M. Abdallah</ext-link>, King Faisal University, Saudi Arabia</p></fn><fn fn-type="edited-by"><p>
<bold>Reviewed by:</bold>
<ext-link xlink:href="https://loop.frontiersin.org/people/793354/overview" ext-link-type="uri">Dean Philip John Kavanagh</ext-link>, University of Birmingham, United Kingdom</p><p>
<ext-link xlink:href="https://loop.frontiersin.org/people/1354856/overview" ext-link-type="uri">Makram Merimi</ext-link>, Universit&#x000e9; Libre de Bruxelles, Belgium</p></fn><corresp id="c001">*Correspondence: Juan Huang, <email>huangjuan720@zmu.edu.cn</email>; Nanqu Huang, <email>hnq@zmu.edu.cn</email>; Yong Luo, <email>luoyong@zmu.edu.cn</email>
</corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>13</volume><elocation-id>1446537</elocation-id><history><date date-type="received"><day>10</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>25</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Wu, Ge, Huang, Zhang, Huang, Huang and Luo.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Wu, Ge, Huang, Zhang, Huang, Huang and Luo</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Mesenchymal stem cells (MSCs) have the potential to differentiate into various cell types, providing important sources of cells for the development of regenerative medicine. Although MSCs have various advantages, there are also various problems, such as the low survival rate of transplanted cells and poor migration and homing; therefore, determining how to reform MSCs to improve their utilization is particularly important. Although many natural bioactive compounds have shown great potential for improving MSCs, many mechanisms and pathways are involved; however, in the final analysis, natural bioactive compounds promoted MSC proliferation, migration and homing and promoted differentiation and antiaging. This article reviews the regulatory effects of natural bioactive compounds on MSCs to provide new ideas for the therapeutic effects of modified MSCs on diseases.</p></abstract><kwd-group><kwd>mesenchymal stem cells</kwd><kwd>natural bioactive compounds</kwd><kwd>resveratrol</kwd><kwd>icariin</kwd><kwd>Ginkgo biloba extract</kwd><kwd>tanshinone IIA</kwd><kwd>astragaloside IV</kwd><kwd>curcumin</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the National Natural Science Foundation of China (82160858), Science and Technology Department of Guizhou Province [ZK (2024)-680, ZK (2021)-570], Zunyi Science and Technology Bureau [(2024) No. 6, HZ-2022-45], and funds of The First People&#x02019;s Hospital of Zunyi for Research and Experimental Development (R&#x00026;D 2020-06).</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Tissue Engineering and Regenerative Medicine</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><title>1 Introduction</title><p>There are many types of stem cells that can be divided into three categories: embryonic stem cells derived from early embryos, induced pluripotent stem cells, and adult stem cells, including haematopoietic stem cells, neural stem cells, and mesenchymal stem cells (MSCs) (<xref rid="B126" ref-type="bibr">Tian et al., 2023</xref>). MSCs were first discovered from bone marrow in 1976 (<xref rid="B69" ref-type="bibr">Lan et al., 2021</xref>) and have been found in almost all tissues in the human body. Compared with unipotent stem cells, stem cells have high self-renewal ability and good differentiation ability. The pluripotency of MSCs manifests in their ability to differentiate into bone cells, chondrocytes, fat cells, and other cell lines. Bone marrow and subcutaneous fat are the preferred sources of MSCs (<xref rid="B165" ref-type="bibr">Zhou and Shi, 2023</xref>; <xref rid="B25" ref-type="bibr">Eirin et al., 2024</xref>). MSCs can also be isolated from various adult tissues, such as adipose tissue (<xref rid="B36" ref-type="bibr">Gou et al., 2024</xref>), synovial membrane (<xref rid="B72" ref-type="bibr">Li et al., 2020</xref>), dental pulp (<xref rid="B146" ref-type="bibr">Yang et al., 2025</xref>), skin (<xref rid="B110" ref-type="bibr">Rendra et al., 2023</xref>), peripheral blood (<xref rid="B18" ref-type="bibr">Chen et al., 2023</xref>), nasal olfactory mucosa (<xref rid="B129" ref-type="bibr">Valipour et al., 2024</xref>), lung (<xref rid="B109" ref-type="bibr">Rangasamy et al., 2021</xref>), breast milk (<xref rid="B108" ref-type="bibr">Rahmani-Moghadam et al., 2022</xref>), muscle (<xref rid="B115" ref-type="bibr">Serteyn et al., 2024</xref>), periosteum (<xref rid="B149" ref-type="bibr">Ye et al., 2024</xref>), corneal limbus (<xref rid="B113" ref-type="bibr">Santra et al., 2024</xref>), endometrial and menstrual blood (<xref rid="B121" ref-type="bibr">Song et al., 2024</xref>), cervix (<xref rid="B26" ref-type="bibr">Eiro et al., 2024</xref>), and foetal/neonatal tissue (<xref rid="B125" ref-type="bibr">Thiruvenkataramani et al., 2024</xref>). MSCs are good candidates for future experimental or clinical applications and have received increasing attention (<xref rid="B90" ref-type="bibr">Matsuzaka and Yashiro, 2024</xref>; <xref rid="B101" ref-type="bibr">Pharoun et al., 2024</xref>; <xref rid="B117" ref-type="bibr">Shan et al., 2024</xref>). Stem cells have three important functions that make them potentially useful. The first is homing, which is the chemotactic effect of stem cells when damage occurs in the body (<xref rid="B44" ref-type="bibr">Han et al., 2022</xref>). The second is differentiation, whereby stem cells can differentiate into a variety of cell types by means of transplantation and by adding or replacing damaged tissue to enhance functional recovery (<xref rid="B97" ref-type="bibr">Nie et al., 2023</xref>). The third is the secretion of bioactive factors, which may influence local and systemic physiological processes (<xref rid="B21" ref-type="bibr">Daneshmandi et al., 2020</xref>). The most important function of stem cells is self-renewal (<xref rid="B139" ref-type="bibr">Wilkinson et al., 2020</xref>).</p><p>The contribution of stem cells to modern medicine is crucial. Not only because they can be widely used in basic research but also because they offer more and better opportunities to develop new treatment strategies (<xref rid="B101" ref-type="bibr">Pharoun et al., 2024</xref>). Their properties make them valuable for a wide range of applications in the biological and medical sciences (<xref rid="B82" ref-type="bibr">Lu et al., 2025</xref>). MSCs play a wide range of physiological roles, including maintaining tissue homeostasis and regeneration (<xref rid="B164" ref-type="bibr">Zhidu et al., 2024</xref>), as well as modulating immune effects (<xref rid="B45" ref-type="bibr">Hazrati et al., 2024</xref>). As a result, indications for MSCs have expanded to include graft-versus-host disease, multiple sclerosis, Crohn&#x02019;s disease, amyotrophic lateral sclerosis, myocardial infarction, and acute respiratory distress syndrome (ARDS) (<xref rid="B44" ref-type="bibr">Han et al., 2022</xref>; <xref rid="B101" ref-type="bibr">Pharoun et al., 2024</xref>). Over the past decade, several preclinical studies and more than 5,000 clinical trials involving MSCs have been registered, with more than 1,500 completed (<xref rid="B2" ref-type="bibr">Al-Azab et al., 2023</xref>). In addition, more than 100 clinical trials have tested stem cells for regenerative medicine, and MSCs have great potential in treating Parkinson&#x02019;s disease, among other conditions (<xref rid="B1" ref-type="bibr">Abbott, 2025</xref>). Although the clinical application of stem cells is promising, there are still some challenges that warrant consideration in cell therapy and regenerative medicine. Studies have shown that most MSCs lose their biological activity within a week, even after the orthotopic transplantation of MSCs (<xref rid="B104" ref-type="bibr">Preda et al., 2021</xref>). Moreover, most transplanted MSCs are concentrated in pulmonary microvessels, and the amount of targeted tissues is limited (<xref rid="B117" ref-type="bibr">Shan et al., 2024</xref>). Therefore, even though MSCs have various advantages, there are also various challenges, such as the low survival rate of transplanted cells and poor migration and homing of MSCs; thus, the function of MSCs is limited. Currently, various studies have shown that they can increase the survival, migration, proliferation and differentiation of stem cells; promote homing; and induce the release of nutrient factors in various ways to further promote the recovery of neural function (<xref rid="B43" ref-type="bibr">Han et al., 2024</xref>). Some studies have been conducted to pretreat stem cells before injection to change some of the characteristics of the cells, thereby improving the efficacy of stem cell transplantation (<xref rid="B57" ref-type="bibr">Huang et al., 2018</xref>; <xref rid="B152" ref-type="bibr">Yu et al., 2023</xref>) (<xref rid="F1" ref-type="fig">Figure 1</xref>).</p><fig position="float" id="F1"><label>FIGURE 1</label><caption><p>Source and function summary diagram of the MSCs. <bold>(A)</bold> Three important functions of stem cells: homing, differentiation, and secretion. <bold>(B)</bold> The main challenges associated with stem cells are their higher concentration in pulmonary microvessels, low survival rates, and poor migration and homing. <bold>(C)</bold> The source of the stem cells.</p></caption><graphic xlink:href="fbioe-13-1446537-g001" position="float"/></fig><p>According to the World Health Organization (WHO), two-thirds of the world&#x02019;s population has access to herbal medicines. Therefore, the WHO encourages the inclusion of plants in treatment regimens for various diseases to improve their effectiveness and reduce potential costs (<xref rid="B91" ref-type="bibr">Mekhemar et al., 2020</xref>). Natural bioactive compounds are defined as chemical substances derived from natural sources (such as plants, animals, or microorganisms) that have biological effects on living organisms, tissues, or cells. Plants constitute one of their main sources (<xref rid="B73" ref-type="bibr">Li et al., 2024</xref>). Since ancient times, plant-derived natural compounds have been widely used to treat various diseases (<xref rid="B40" ref-type="bibr">Gugliandolo et al., 2020</xref>; <xref rid="B55" ref-type="bibr">Huang et al., 2024</xref>). In recent years, increasing attention has been given to natural bioactive compounds, and the modification of stem cells is a new research direction. They are able to modulate stem cell self-renewal and differentiation potential and target a wide range of types of intracellular signal transduction (<xref rid="B28" ref-type="bibr">Feng et al., 2022</xref>; <xref rid="B70" ref-type="bibr">Li et al., 2023</xref>; <xref rid="B73" ref-type="bibr">Li et al., 2024</xref>). An increasing amount of data show that natural bioactive compounds may have different protective mechanisms through their antioxidants, free radical scavengers, harmful metal ion chelators, regulation of cell survival genes and signals, and antiapoptotic activity, so they have a wide range of applications in the treatment of many diseases (<xref rid="B51" ref-type="bibr">Huang et al., 2023</xref>; <xref rid="B99" ref-type="bibr">Pacyga et al., 2024</xref>; <xref rid="B132" ref-type="bibr">Wang et al., 2024</xref>). In addition to treating diseases, some natural bioactive compounds can also play an antioxidant role by activating the proliferation of lymphocytes to enhance immune function, increasing the number of natural killer (NK) cells and scavenging free radicals (<xref rid="B67" ref-type="bibr">Kim et al., 2022</xref>; <xref rid="B88" ref-type="bibr">Mahmoudi et al., 2024</xref>). Studies have shown that natural bioactive compounds may be able to effectively regulate the proliferation and differentiation of stem cells (<xref rid="B68" ref-type="bibr">Lakshminarayanan et al., 2025</xref>). Therefore, natural bioactive compounds have the potential to be a new source for improving stem cells, increasing their proliferation and improving their function. In this work, the regulatory effects of natural bioactive compounds on MSCs were reviewed to provide better theoretical support for the improvement of stem cells and enhance their application in clinical and basic research.</p></sec><sec id="s2"><title>2 Overview of MSCs</title><p>MSCs are pluripotent stem cells that can self-renew and differentiate into multilineage cells (<xref rid="B77" ref-type="bibr">Lin et al., 2022</xref>). These cells have the ability to differentiate into osteoblasts, chondrocytes, and adipocytes, and the cell phenotypes CD73, CD90, and CD105 are positive, while the major histocompatibility complex class II (MHC-II), CD11b, CD14, CD31, CD34, and CD45 are negative (<xref rid="B165" ref-type="bibr">Zhou and Shi, 2023</xref>; <xref rid="B15" ref-type="bibr">Cao et al., 2024</xref>). The quality and criteria of MSCs should include cell surface markers, differentiation potential and other necessary parameters. These parameters include cell surface labelling profiles, bone formation capacity in the model, as well as cell and particle sizes, telomere length, state of ageing, secretion of trophic factors (secretomes), and immune regulation (<xref rid="B127" ref-type="bibr">Trivanovi&#x00107; et al., 2015</xref>; <xref rid="B112" ref-type="bibr">Samsonraj et al., 2017</xref>). Because MSCs are easy to extract from foetal and adult tissues and do not require overly demanding cell culture conditions, they are promising research targets. Many studies have confirmed their anti-inflammatory components, multilineage potential, tissue regeneration ability and immunomodulatory effects, so they have been widely studied in the treatment of many diseases (<xref rid="B3" ref-type="bibr">Al-Azab et al., 2022</xref>; <xref rid="B35" ref-type="bibr">Gopalarethinam et al., 2023</xref>).</p><sec id="s2-1"><title>2.1 Bone marrow mesenchymal stem cells (BMSCs)</title><p>BMSCs are the most widely used stem cells in regenerative medicine and tissue engineering. They are nonhematopoietic stem cells that exist in the bone marrow and have pluripotent differentiation potential (<xref rid="B159" ref-type="bibr">Zhang et al., 2023</xref>). However, the mobilization of BMSCs from the bone marrow and their migration to damaged tissue during healing are key issues. The migration of BMSCs to target tissues is a complex biological process. This transport process is affected by many factors, such as chemical factors (e.g., chemokines, cytokines, and growth factors) and mechanical factors (e.g., shear stress and vascular circulation) (<xref rid="B29" ref-type="bibr">Fu et al., 2019</xref>). At present, several methods are used to evaluate the migration of BMSCs, the most common methods are the Transwell method and the scratch test (<xref rid="B123" ref-type="bibr">Sun and Fan, 2025</xref>). Moreover, BMSCs can also be labelled with fluorescence to track their location (<xref rid="B154" ref-type="bibr">Yun et al., 2023</xref>). The therapeutic use of BMSCs also has certain limitations, such as cell rejection, poor immune response, toxicity, tumorigenicity, potential contamination by viruses and problems with cell transport and storage prior to transplantation (<xref rid="B124" ref-type="bibr">Tayebi et al., 2022</xref>; <xref rid="B160" ref-type="bibr">Zhang et al., 2022</xref>).</p></sec><sec id="s2-2"><title>2.2 Human umbilical cord mesenchymal stem cells (HUCMSCs)</title><p>The human umbilical cord is a promising source of mesenchymal stem cells (HUCMSCs). Unlike that for BMSCs, the process of HUCMSC collection is painless, and HUCMSCs exhibit faster self-renewal. HUCMSCs are a better source than commonly used embryonic stem cells. They can differentiate into three types of germ layers that promote tissue repair, regulate the immune response, and have anticancer properties (<xref rid="B111" ref-type="bibr">Rodr&#x000ed;guez-Eguren et al., 2022</xref>). However, HUCMSCs also have certain limitations, such as maintaining biological activity and quantifying bioactive substances (<xref rid="B23" ref-type="bibr">Ding et al., 2018</xref>).</p></sec><sec id="s2-3"><title>2.3 Adipose-derived mesenchymal stem cells (ASCs)</title><p>ASCs are generally isolated from heterogeneous cell populations produced in the stromal vascular fraction (SVF) of adipose tissue. The SVF is obtained from subcutaneous fat tissue from individuals who undergo surgical procedures such as liposuction to remove excess, unwanted fat, so easy access to sources is one reason for its widespread use (<xref rid="B148" ref-type="bibr">Yaylac&#x00131; et al., 2023</xref>). ASCs can self-renew and differentiate into multiple cell lines. ASCs have been proven to have anti-inflammatory, antifibrotic, antiapoptotic and proangiogenic effects both <italic>in vitro</italic> and <italic>in vivo.</italic> Therefore, they have been widely used in cell therapy and regenerative medicine (<xref rid="B4" ref-type="bibr">Al-Ghadban et al., 2022</xref>; <xref rid="B156" ref-type="bibr">Zeng et al., 2022</xref>; <xref rid="B10" ref-type="bibr">Barone et al., 2023</xref>). ASCs are widely used in many diseases, such as multiple sclerosis, diabetes, Crohn&#x02019;s disease, SLE, and graft-versus-host disease (<xref rid="B4" ref-type="bibr">Al-Ghadban et al., 2022</xref>). Unlike BMSCs, ASCs differ in that their fatty acid translocase marker CD36 and cell adhesion marker CD106 are not expressed (<xref rid="B103" ref-type="bibr">Poon et al., 2020</xref>). Previous reports have shed new light on the ability of ASCs to differentiate. ASCs can differentiate into various types of epithelial cells, such as renal tubular epithelial cells and retinal pigment epithelial cells (<xref rid="B17" ref-type="bibr">Cawthorn et al., 2012</xref>). However, other researchers have demonstrated that these cells may have less potential for bone formation and cartilage formation than BMSCs. The importance of adipose tissue-derived stem cells has been questioned (<xref rid="B5" ref-type="bibr">Al-Sammarraie et al., 2024</xref>).</p></sec><sec id="s2-4"><title>2.4 Other types of mesenchymal stem cells</title><p>Other well-known sources of adult MSCs include the cervix, placenta, amniotic fluid, dental pulp, breast milk, and synovial membrane. Compared with other methods used to obtain other MSCs (such as bone marrow or adipose tissue), human cervical stem cells (hUCESCs) are also a type of MSC that can be obtained via cervical smears, are easy to separate, have a high proliferation rate, and can yield a greater number of hUCESCs or exosomes and other derivatives, which is conducive to basic research and clinical applications (<xref rid="B131" ref-type="bibr">Vizoso et al., 2017</xref>; <xref rid="B32" ref-type="bibr">Ge et al., 2024</xref>). Compared with MSCs from other sources, human placental mesenchymal stem cells (hPMSCs) have the advantages of stable proliferation and low immunogenicity. These properties make hPMSCs ideal materials for stimulating tissue repair (<xref rid="B83" ref-type="bibr">Lu et al., 2021</xref>; <xref rid="B153" ref-type="bibr">Yu et al., 2024</xref>). Amniotic fluid MSCs are a type of MSC produced during the perinatal period. Compared with adult MSCs such as BMSCs, their advantages include a minimally invasive separation process, more primitive cell characteristics, nontumorigenicity, and low immunogenicity. Currently, they have received increasing attention (<xref rid="B24" ref-type="bibr">Doktor et al., 2025</xref>). On the basis of the clinical diagnosis of nonfunctional or pathogenic tissues in the mouth, oral MSCs can be obtained through minimally invasive surgery. In addition, they are often discarded as medical waste after they are removed from the mouth. Therefore, compared with the use of MSCs from other tissues, this is a unique advantage of dental MSCs in research (<xref rid="B89" ref-type="bibr">Masuda et al., 2021</xref>).</p></sec></sec><sec id="s3"><title>3 Effects of different types of natural bioactive compounds on MSCs</title><p>Because MSCs are good candidates for clinical and basic research, it is especially important to obtain adequate numbers of these cells. They are usually cultured <italic>in vitro</italic> with animal serum and various growth factors. However, repeated freeze&#x02012;thaw cycles, <italic>in vitro</italic> culture conditions and continuous passages during the culture process have adverse effects on the proliferation of MSCs, such as reduced self-renewal, increased cell senescence, increased apoptosis and premature differentiation, and these cells are very susceptible to the influence of the microenvironment (<xref rid="B147" ref-type="bibr">Yang et al., 2018</xref>; <xref rid="B104" ref-type="bibr">Preda et al., 2021</xref>). A variety of natural bioactive compounds are used worldwide to treat and prevent various diseases, and they have multitarget, multilevel and multipathway characteristics (<xref rid="B51" ref-type="bibr">Huang et al., 2023</xref>). The bioactive compounds naturally present in seaweed, herbs, fruits, and vegetables have the ability to regulate the self-renewal and differentiation potential of adult stem cells. They mainly target a wide range of intracellular signal transduction pathways (<xref rid="B71" ref-type="bibr">Li et al., 2022</xref>). Natural plant compounds can improve the rate of tissue regeneration, which has certain advantages in the tissue engineering of stem cell therapy and alternative therapy. Although bioactive ingredients have not been widely used in the clinic because of their variability and complexity, a growing number of studies have focused on the modified effects of natural compounds on MSCs (<xref rid="T1" ref-type="table">Table 1</xref>) (<xref rid="F2" ref-type="fig">Figure 2</xref>).</p><table-wrap position="float" id="T1"><label>TABLE 1</label><caption><p>Effect of natural bioactive compounds modified mesenchymal stem cells.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">Compounds</th><th align="left" rowspan="1" colspan="1">Sources of MSC</th><th align="left" rowspan="1" colspan="1">Function</th><th align="left" rowspan="1" colspan="1">Mechanism of action</th><th align="left" rowspan="1" colspan="1">Ref</th></tr></thead><tbody valign="top"><tr><td rowspan="5" align="left" colspan="1">Icariin</td><td rowspan="4" align="left" colspan="1">BMSC</td><td rowspan="2" align="left" colspan="1">1.Promote proliferation and osteogenic differentiation of BMSC, inhibit lipogenic differentiation</td><td align="left" rowspan="1" colspan="1">1.Upregulated Runx2, ALP and I collagen promote bone formation, the expression of PPAR&#x003b3;, adipsin, CCAAT/C/EBP&#x003b1; and FABP4 mRNA was inhibited to inhibit the differentiation of BMMSC into adipocytes</td><td rowspan="4" align="left" colspan="1">
<xref rid="B119" ref-type="bibr">Sheng et al. (2013),</xref>
<xref rid="B53" ref-type="bibr">Huang et al. (2017),</xref>
<xref rid="B78" ref-type="bibr">Liu et al. (2017),</xref>
<xref rid="B142" ref-type="bibr">Wu et al. (2017),</xref>
<xref rid="B76" ref-type="bibr">Lim et al. (2018)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">2.Activation of STAT-3 increases the activity and expression of cysteine (C)-X-C motif chemokine receptor 4 (CXCR4)</td></tr><tr><td rowspan="2" align="left" colspan="1">2.Promote migration of BMSCs</td><td align="left" rowspan="1" colspan="1">3. Stimulate the MAPK signaling pathway</td></tr><tr><td align="left" rowspan="1" colspan="1">4.Stimulation of Wnt/&#x003b2;-catenin signaling pathway</td></tr><tr><td align="left" rowspan="1" colspan="1">ASCs</td><td align="left" rowspan="1" colspan="1">Promote osteogenic differentiation</td><td align="left" rowspan="1" colspan="1">The mRNA expression of ALP, Col-1 and OC, Dlx5 and Runx2, BMP-2, -4 and -7 genes was stimulated. Improve Runx2, bmp and OC levels</td><td align="left" rowspan="1" colspan="1">
<xref rid="B145" ref-type="bibr">Yang et al. (2019),</xref>
<xref rid="B118" ref-type="bibr">Sharifi et al. (2020)</xref>
</td></tr><tr><td rowspan="3" align="left" colspan="1">Resveratrol</td><td align="left" rowspan="1" colspan="1">BMSC</td><td align="left" rowspan="1" colspan="1">Promote proliferation and osteogenic differentiation of BMSC, inhibit lipogenic differentiation. Promote homing of MSC.</td><td align="left" rowspan="1" colspan="1">Runx2 gene expression on the SIRT1/FOXO3A axis can also be upregulated through ERK1/2 and MAPK signaling pathways</td><td align="left" rowspan="1" colspan="1">
<xref rid="B20" ref-type="bibr">Dai et al. (2007),</xref>
<xref rid="B169" ref-type="bibr">Tseng et al. (2011)</xref>, <xref rid="B170" ref-type="bibr">Okay et al. (2015)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">HUCMSCs</td><td align="left" rowspan="1" colspan="1">Increase cell vitality, slow down aging and aging</td><td align="left" rowspan="1" colspan="1">Increase SIRT1 level, inhibiting the expression of p53 and p16</td><td align="left" rowspan="1" colspan="1">
<xref rid="B135" ref-type="bibr">Wang et al. (2016)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">ASCs</td><td align="left" rowspan="1" colspan="1">Enhance the epithelial and osteogenic differentiation of MSCs</td><td align="left" rowspan="1" colspan="1">ASC differentiation was induced on collagen scaffolds</td><td align="left" rowspan="1" colspan="1">
<xref rid="B167" ref-type="bibr">Wang et al. (2018)</xref>
</td></tr><tr><td rowspan="2" align="left" colspan="1">Ginkgo biloba extract</td><td rowspan="2" align="left" colspan="1">BMSC</td><td rowspan="2" align="left" colspan="1">Promote proliferation and osteogenic differentiation of BMSC</td><td align="left" rowspan="1" colspan="1">1.Promotes osteogenesis by up-regulating BMP and Wnt/&#x003b2;-catenin signaling pathways</td><td rowspan="2" align="left" colspan="1">
<xref rid="B38" ref-type="bibr">Gu et al. (2015)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">2. Upregulated PAX6 expression in cells</td></tr><tr><td rowspan="5" align="left" colspan="1">Tanshinone IIA</td><td rowspan="3" align="left" colspan="1">BMSC</td><td align="left" rowspan="1" colspan="1">1.Better anti-neuroinflammatory effects</td><td align="left" rowspan="1" colspan="1">1.Downregulated BACE1 expression</td><td rowspan="3" align="left" colspan="1">
<xref rid="B161" ref-type="bibr">Zhang et al. (2018),</xref>
<xref rid="B56" ref-type="bibr">Huang et al. (2019),</xref>
<xref rid="B168" ref-type="bibr">Yuan et al. (2022)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">2.Promote the differentiation of neuron cells</td><td align="left" rowspan="1" colspan="1">2.It may improve the survival rate of transplanted BMSCs, increase the level of nutrient factors secreted by BMSCs to the lesion area, and reduce inflammatory cytokines</td></tr><tr><td align="left" rowspan="1" colspan="1">Promote hBMSCs proliferation</td><td align="left" rowspan="1" colspan="1">3.Increase the release of fibroblast growth factor 2 (FGF2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Human periodontal ligament stem cells (hPDLSC)</td><td align="left" rowspan="1" colspan="1">It promotes this differentiation and hPDLSC maturation</td><td align="left" rowspan="1" colspan="1">Osteogenesis of hPDLSC was induced by the ERK1/2-Runx2 axis</td><td align="left" rowspan="1" colspan="1">
<xref rid="B80" ref-type="bibr">Liu et al. (2019)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">MSC</td><td align="left" rowspan="1" colspan="1">Regulate the migration ability of MSC.</td><td align="left" rowspan="1" colspan="1">Regulate the expression of CXCR4</td><td align="left" rowspan="1" colspan="1">
<xref rid="B143" ref-type="bibr">Xie et al. (2013)</xref>
</td></tr><tr><td rowspan="6" align="left" colspan="1">Curcumin</td><td rowspan="3" align="left" colspan="1">BMSC</td><td rowspan="2" align="left" colspan="1">1.Delay the aging</td><td align="left" rowspan="1" colspan="1">1.Activated autophagy</td><td rowspan="3" align="left" colspan="1">
<xref rid="B37" ref-type="bibr">Gu et al. (2012),</xref>
<xref rid="B136" ref-type="bibr">Wang et al. (2019),</xref>
<xref rid="B171" ref-type="bibr">Chen et al. (2021)</xref>, <xref rid="B22" ref-type="bibr">Deng et al. (2021)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">2.It is associated with HO-1 expression</td></tr><tr><td align="left" rowspan="1" colspan="1">2.Promote osteogenic differentiation. Inhibition of lipogenic differentiation</td><td align="left" rowspan="1" colspan="1">The expression of Kruppel-like factor 15 was inhibited</td></tr><tr><td rowspan="2" align="left" colspan="1">ASCs</td><td rowspan="2" align="left" colspan="1">Delay the aging</td><td align="left" rowspan="1" colspan="1">1.Increase the expression of TERT gene</td><td rowspan="2" align="left" colspan="1">
<xref rid="B79" ref-type="bibr">Liu et al. (2015),</xref>
<xref rid="B102" ref-type="bibr">Pirmoradi et al. (2018)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">2.Increased tolerance to oxidative stress damage</td></tr><tr><td align="left" rowspan="1" colspan="1">hDP-MSC</td><td align="left" rowspan="1" colspan="1">Enhance immune regulation and regeneration</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="B8" ref-type="bibr">Ayadilord et al. (2022)</xref>
</td></tr><tr><td rowspan="4" align="left" colspan="1">Astragaloside</td><td align="left" rowspan="1" colspan="1">MSC</td><td align="left" rowspan="1" colspan="1">Promotes angiogenesis of endothelium-like cells</td><td align="left" rowspan="1" colspan="1">Upregulated expression of Cx37, Cx 40 and Cx43</td><td align="left" rowspan="1" colspan="1">
<xref rid="B74" ref-type="bibr">Li et al. (2018)</xref>
</td></tr><tr><td rowspan="2" align="left" colspan="1">ASCs</td><td align="left" rowspan="1" colspan="1">1.Enhance its ability to proliferate</td><td align="center" rowspan="1" colspan="1">1.Decreased PC-I secretion and increased MMP-1 release were induced in fibroblasts</td><td rowspan="2" align="left" colspan="1">
<xref rid="B98" ref-type="bibr">Niu et al. (2020),</xref>
<xref rid="B134" ref-type="bibr">Wang et al. (2022)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">2.Promote migration and homing</td><td align="center" rowspan="1" colspan="1">2.FAK phosphorylation induced by CXCR2</td></tr><tr><td align="left" rowspan="1" colspan="1">hBMSCs</td><td align="left" rowspan="1" colspan="1">Ability to promote proliferation and differentiation</td><td align="left" rowspan="1" colspan="1">Regulated by the miR-124-3p.1/STAT3 axis</td><td align="left" rowspan="1" colspan="1">
<xref rid="B16" ref-type="bibr">Cao et al. (2021)</xref>
</td></tr><tr><td rowspan="3" align="left" colspan="1">Ginsenoside Rg1</td><td rowspan="3" align="left" colspan="1">BMSCs</td><td rowspan="2" align="left" colspan="1">1.Delay the aging</td><td align="left" rowspan="1" colspan="1">1.Inhibition of phosphorylation of GSK-3&#x003b2;</td><td rowspan="3" align="left" colspan="1">
<xref rid="B39" ref-type="bibr">Gu et al. (2016),</xref>
<xref rid="B137" ref-type="bibr">Wang et al. (2020),</xref>
<xref rid="B138" ref-type="bibr">Wang et al. (2021)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">2.Activation of AKT or NRF2</td></tr><tr><td align="left" rowspan="1" colspan="1">2.Promote osteogenic differentiation</td><td align="left" rowspan="1" colspan="1">3.Example Activate the GR/BMP-2 signal path</td></tr><tr><td align="left" rowspan="1" colspan="1">Thymoquinone</td><td align="left" rowspan="1" colspan="1">G-MSCs</td><td align="left" rowspan="1" colspan="1">Promotes cell transformation into an immunocompetent differentiated phenotype</td><td align="left" rowspan="1" colspan="1">Increase the expression of TLR3</td><td align="left" rowspan="1" colspan="1">
<xref rid="B92" ref-type="bibr">Mekhemar et al. (2022)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Breast CSCs</td><td align="left" rowspan="1" colspan="1">Wnt/PI3K signaling pathway</td><td align="left" rowspan="1" colspan="1">Altered angiogenesis capacity and mesenchymal to epithelial transformation</td><td align="left" rowspan="1" colspan="1">(<xref rid="B42" ref-type="bibr">Haiaty et al., 2021b</xref>; <xref rid="B41" ref-type="bibr">a</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">MSCs</td><td align="left" rowspan="1" colspan="1">Promote differentiation</td><td align="left" rowspan="1" colspan="1">Triggers inhibition of NF-&#x003ba;B signaling</td><td align="left" rowspan="1" colspan="1">
<xref rid="B107" ref-type="bibr">Rahmani-Moghadam et al. (2021),</xref>
<xref rid="B9" ref-type="bibr">Banu (2022),</xref>
<xref rid="B59" ref-type="bibr">Ishaque et al. (2022)</xref>
</td></tr><tr><td rowspan="2" align="left" colspan="1">Ptychotis verticillate</td><td rowspan="2" align="left" colspan="1"/><td align="left" rowspan="1" colspan="1">1. Promote migration</td><td rowspan="2" align="left" colspan="1">PI3K and MAPK signaling pathways</td><td rowspan="2" align="left" colspan="1">
<xref rid="B87" ref-type="bibr">Maeda, 2020</xref>; <xref rid="B95" ref-type="bibr">Najar et al. (2024)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">2. Immunomodulation</td></tr></tbody></table></table-wrap><fig position="float" id="F2"><label>FIGURE 2</label><caption><p>Effects of different types of natural bioactive compounds on MSCs. This simple schematic diagram mainly illustrates the effects of different types of natural bioactive compounds on MSCs. The chemical structures and main sources of the nine representative ingredients on the grey outside the circle include resveratrol (RSVL), icariin (ICA), Ginkgo biloba extract (GBE), tanshinone IIA (Tan IIA), astragaloside IV (AGS-IV), curcumin, ginsenoside Rg1, thymoquinone (TQ), and Ptychotis verticillata (PV).</p></caption><graphic xlink:href="fbioe-13-1446537-g002" position="float"/></fig><sec id="s3-1"><title>3.1 Resveratrol</title><p>Resveratrol (RSVL) is a natural polyphenol plant antitoxin (<xref rid="B52" ref-type="bibr">Huang et al., 2020</xref>; <xref rid="B51" ref-type="bibr">Huang et al., 2023</xref>) and is a natural polyphenolic phytoestrogen. It was first found in the root extract of white mustard (<italic>Veratrum grandiflorum</italic>) and was found in the roots of <italic>knotweed</italic> in 1963 (<xref rid="B130" ref-type="bibr">Vauzour, 2012</xref>). RSVL has two configurations, cis-type or trans-type structures, among which trans-RSVL is the main form existing in nature and the most widely studied form (<xref rid="B52" ref-type="bibr">Huang et al., 2020</xref>). RSVL has a wide range of biological activities, including antioxidant, antiviral, anti-inflammatory, antiaging and anticancer properties (<xref rid="B66" ref-type="bibr">Khattar et al., 2022</xref>). It has great potential to prevent a variety of acute and chronic diseases. Recent studies have shown that it can play a reliable rejuvenating role in various animal models, tissues and organs, especially in the modification of stem cells. Studies have shown that RSVL can improve the therapeutic effect of MSCs by increasing their survival rate, self-renewal ability and antiaging effects (<xref rid="B49" ref-type="bibr">Hu and Li, 2019</xref>). RSVL is also involved in the regulation of bone formation and fat, as well as nerve regeneration, in MSCs (<xref rid="B64" ref-type="bibr">Joe et al., 2015</xref>).</p><p>In terms of the antiaging effects of MSCs on BMSCs, studies have shown that RSVL can activate Sirtuin 1 (SIRT1), reduce &#x003b2;-catenin activity, increase extracellular signal-regulated kinase (ERK) phosphorylation and glycogen synthase kinase-3 beta (GSK-3&#x003b2;) phosphorylation, improve the self-renewal potential of early-passage MSCs and improve their pluripotency (<xref rid="B150" ref-type="bibr">Yoon et al., 2015</xref>). Different concentrations of RSVL had different antiaging effects on HUCMSCs. At 0.1, 1 and 2.5&#x000a0;&#x003bc;M, RSVL promoted cell viability and slowed the ageing of MSCs by increasing SIRT1 expression and inhibiting p53 and p16 expression. At concentrations of 5 and 10&#x000a0;&#x003bc;M, RSVL can increase the degree of senescence and apoptosis of MSCs by inhibiting SIRT1 and PCNA and stimulating the expression of p53 and p16 (<xref rid="B135" ref-type="bibr">Wang et al., 2016</xref>). Therefore, not all concentrations of RSVL are beneficial for the growth of MSCs.</p><p>RSVL is involved in the differentiation of MSCs. Studies have shown that RSVL can enhance the osteogenic differentiation ability of BMSCs by increasing NO production and the cGMP content, activating ERK1/2 and p38 mitogen-activated protein kinase (MAPK), and upregulating the expression of mitogens (<xref rid="B122" ref-type="bibr">Song et al., 2006</xref>; <xref rid="B20" ref-type="bibr">Dai et al., 2007</xref>; <xref rid="B86" ref-type="bibr">Lv et al., 2018</xref>). RSVL can also replace insulin in lipid-forming medium, increase the phosphorylation of cyclic AMP response element binding protein (CREB), and induce lipid differentiation in MSCs (<xref rid="B14" ref-type="bibr">Caldarelli et al., 2015</xref>).</p><p>RSVL has also been shown to improve the regulation of nerve regeneration. In BMSCs, RSVL can upregulate AMPK/SIRT1 signal transduction, thereby increasing the level of neural progenitor cell markers in MSCs isolated from ALS patients (<xref rid="B155" ref-type="bibr">Yun et al., 2019</xref>). In dental pulp stem cells, RSVL can increase the expression of the neuron-specific marker genes <italic>Nestin</italic>, <italic>Musashi</italic> and <italic>NF-M</italic>, thereby promoting the differentiation of dental pulp stem cells into neuronal cells (<xref rid="B34" ref-type="bibr">Geng et al., 2017</xref>). RSVL can activate the phosphatidylinositol 3-kinase (PI3K) signalling pathway or increase the levels of protein kinase A, GSK-3&#x003b2;, and ERK1/2 in HUCMSCs, thereby increasing the expression of neural markers and promoting neural repair (<xref rid="B60" ref-type="bibr">Jahan et al., 2018a</xref>; <xref rid="B61" ref-type="bibr">Jahan et al., 2018b</xref>). Moreover, RSVL can play a positive role in the treatment of periodontitis by promoting the proliferation, osteogenic differentiation and immune regulation of MSCs (<xref rid="B62" ref-type="bibr">Jiang et al., 2023</xref>).</p><p>Thus, although RSVL can regulate the survival of MSCs, it can promote their self-renewal and maintain their pluripotency. However, to some extent, the concentration of RSVL, the time of administration and the method and time of pretreatment all affect the effect of RSVL on MSCs. Moreover, although many studies have focused on RSVL, few studies have investigated RSVL derivatives. Perhaps related studies can be conducted in the future, which will contribute to further exploration of the improvement effect of RSVL on MSCs in regenerative medicine. There are also several contradictory conclusions in the research. For example, some studies have shown that RSVL can help MSCs maintain pluripotency (<xref rid="B150" ref-type="bibr">Yoon et al., 2015</xref>), but other studies have shown that RSVL can lead to the production of neural markers in HUCMSCs (<xref rid="B60" ref-type="bibr">Jahan et al., 2018a</xref>; <xref rid="B61" ref-type="bibr">Jahan et al., 2018b</xref>). This may be related to the different types of MSCs, doses and intervention methods used.</p></sec><sec id="s3-2"><title>3.2 Icariin (ICA)</title><p>ICA is the main bioactive compound of <italic>Epimedium brevicornum Maxim</italic> (<xref rid="B48" ref-type="bibr">Hsieh et al., 2011</xref>). The composition of ICA includes a C-3 glucose group, a C-4 methoxy group, a C-8 isoprene group and a C-7 rhamnosyl group, and it is a class of isoprene flavonoid compounds. The molecular formula of ICA is C<sub>33</sub>H<sub>40</sub>O<sub>15,</sub> and its molecular weight is 676.67&#x000a0;g/mol (<xref rid="B118" ref-type="bibr">Sharifi et al., 2020</xref>). ICA has a variety of pharmacological activities, including hormone-like, antitumour, immunomodulatory and antioxidant effects (<xref rid="B11" ref-type="bibr">Bi et al., 2022</xref>; <xref rid="B116" ref-type="bibr">Seyedi et al., 2023</xref>). ICA has been used to treat many diseases, such as preventing osteoporosis, improving sexual dysfunction, regulating immune system function and improving cardiovascular function (<xref rid="B46" ref-type="bibr">He et al., 2020</xref>).</p><p>As mentioned earlier, while the use of MSCs has many advantages, many methods have been developed, which limits their application. Therefore, new drugs have been developed to promote the proliferation and differentiation of MSCs. The effects of ICA have been extensively studied in animal and <italic>in vitro</italic> models, and its ability to modify MSCs has attracted much attention. The beneficial effect of ICA on MSCs involves promoting osteogenic differentiation and inhibiting lipogenic differentiation. Some studies suggest that this effect is achieved by inactivating GSK-3&#x003b2; and inhibiting the expression of PPAR&#x003b3; (<xref rid="B119" ref-type="bibr">Sheng et al., 2013</xref>). Some studies suggest that this effect is related to the BMP (BMP-2, BMP-4, BMP-7) and MAPK/ERK pathways (<xref rid="B142" ref-type="bibr">Wu et al., 2017</xref>). Some studies suggest that it promotes osteogenesis through the upregulation of Runx2, ALP and I collagen and the Notch signalling pathway and inhibits <italic>PPAR&#x003b3;</italic>, <italic>adipsin</italic> gene expression, and CCAAT/enhancer binding protein &#x003b1; (<italic>C/EBP&#x003b1;</italic>) and fatty acid binding protein 4 (<italic>FABP4</italic>) mRNAs (<xref rid="B53" ref-type="bibr">Huang et al., 2017</xref>; <xref rid="B78" ref-type="bibr">Liu et al., 2017</xref>). EGb 761 may be associated with findings in other studies that have shown that ICA can activate STAT-3 and increase the activity and expression of cysteine (C)-X-C motif chemokine receptor 4 (CXCR4) (<xref rid="B76" ref-type="bibr">Lim et al., 2018</xref>), thus promoting the proliferation and osteogenic differentiation of MSCs. Moreover, ICA can promote BMSC migration by stimulating the MAPK signalling pathway (<xref rid="B63" ref-type="bibr">Jiao et al., 2018</xref>).</p><p>In addition to BMSCs, hADSCs can effectively promote osteogenic differentiation by stimulating the mRNA expression of bone matrix protein (<italic>ALP</italic>, <italic>Col-1</italic>, and <italic>OC</italic>), bone transcription factor (<italic>Dlx5</italic> and <italic>Runx2</italic>), and bone morphogenetic protein (<italic>BMP-2</italic>, <italic>-4</italic>, and <italic>-7</italic>) genes (<xref rid="B145" ref-type="bibr">Yang et al., 2019</xref>; <xref rid="B118" ref-type="bibr">Sharifi et al., 2020</xref>). The beneficial effect of ICA on MSCs involves mainly promoting osteogenic differentiation and inhibiting lipogenic differentiation, and studies on whether ICA can promote proliferation, survival, homing and migration are limited, which also provides ideas for future studies.</p></sec><sec id="s3-3"><title>3.3 Ginkgo biloba extract (GBE)</title><p>GBE is a bioactive component of <italic>Ginkgo biloba L.</italic> with various pharmacological activities (<xref rid="B50" ref-type="bibr">Hu et al., 2023</xref>). Its two main extracts have similar compositions: EGb 761, which has 24% ginkgo flavonoid glycosides and 6% terpenoids, and LI1370, which is composed of 25% ginkgo flavonoid glycosides and 6% terpenoids. GBE has been widely used to treat cerebrovascular insufficiency, peripheral vascular insufficiency, and cognitive impairment associated with ageing and neurodegenerative diseases (such as Alzheimer&#x02019;s disease) because of its ability to improve high blood pressure, antithrombosis, inflammation, oxidative stress, and infection (<xref rid="B94" ref-type="bibr">Mousavi et al., 2022</xref>; <xref rid="B144" ref-type="bibr">Xie et al., 2022</xref>). Specifically, GBE can reduce oxidative stress and inhibit the expression of inflammatory cytokines. In addition, studies have confirmed that GBE can promote the growth and proliferation of different cell types, such as neural stem cells, endothelial progenitor cells, and cochlear hair cells (<xref rid="B38" ref-type="bibr">Gu et al., 2015</xref>).</p><p>Studies have reported that GBE can promote the growth and differentiation of a variety of cells, including neural stem cells and endothelial progenitor cells (<xref rid="B163" ref-type="bibr">Zheng et al., 2018</xref>). Studies have shown that when GBE is in the range of 25&#x02013;75&#x000a0;mg/L, GBE can promote the proliferation and osteogenesis of human BMSCs by upregulating the BMP and Wnt/&#x003b2;-catenin signalling pathways. When the concentration of GBE was 100&#x000a0;mg/L or above, the ability of GBE to promote the proliferation of BMSCs weakened or disappeared (<xref rid="B38" ref-type="bibr">Gu et al., 2015</xref>). The concentration of GBE is particularly important for the modification of BMSCs, which directly determines whether the growth of MSCs is promoted or inhibited; thus, special attention should be given to GBE concentrations in future studies. In rat models of myocardial infarction, EGb 761 may mediate the protective effect of EGb on myocardial infarction by increasing the implantation rate of MSCs, thereby improving the viability and differentiation of cardiomyocytes (<xref rid="B81" ref-type="bibr">Liu et al., 2014</xref>). Other studies have shown that MSCs modified with GBE may have good applications in the treatment of local inflammation and the oxidative microenvironment (<xref rid="B38" ref-type="bibr">Gu et al., 2015</xref>). Hence, these findings underscore the concentration-dependent therapeutic potential of GBE in stem cell-based neuroregeneration.</p></sec><sec id="s3-4"><title>3.4 Tanshinone IIA (Tan IIA)</title><p>Tan IIA, a bioactive ingredient isolated from the herb <italic>Salvia miltiorrhiza Bge</italic>, is an antioxidant and anti-inflammatory agent that inhibits the cytotoxicity of damaged tissues, significantly improves blood circulation and delays tumour progression (<xref rid="B157" ref-type="bibr">Zeng et al., 2021</xref>; <xref rid="B96" ref-type="bibr">Ng et al., 2022</xref>). Studies have shown that Tan IIA has the potential to reduce oxidative stress by regulating the levels of antioxidant enzymes, including glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase. The anti-inflammatory effect of Tan IIA may be mediated by weakened inflammatory mediators in RAW264.7 macrophages, namely, interleukin (IL)-1&#x003b2;, IL-6 and tumour necrosis factor (TNF)-&#x003b1; (<xref rid="B6" ref-type="bibr">Ansari et al., 2021</xref>).</p><p>With respect to the modification effect of Tan IIA on MSCs, Tan IIA can regulate the migration ability of MSCs. Studies have shown that Tan IIA is at least partially regulated by regulating CXCR4 expression (<xref rid="B143" ref-type="bibr">Xie et al., 2013</xref>). Tan IIA can improve the survival rate of MSCs, and some researchers have reported that Tan IIA can promote the differentiation of transplanted BMSCs into neurocell-like cells in SCI models. The hypothesized mechanism is that TIIA can improve the survival rate of transplanted BMSCs, increase the level of nutrient factors secreted by BMSCs to the lesion area, and reduce the secretion of inflammatory cytokines (<xref rid="B161" ref-type="bibr">Zhang et al., 2018</xref>). Tan IIA may better induce the osteogenic ability of MSCs. Studies have confirmed that Tan IIA can induce hPDLSC osteogenesis through the ERK1/2-Runx2 axis, which provides a choice in regenerative medicine approaches for the treatment of periodontitis (<xref rid="B80" ref-type="bibr">Liu et al., 2019</xref>). However, Tan IIA-modified MSCs can play a better role; for example, researchers have reported that Tan IIA-pretreated stem cells can reduce neuronal death by increasing the levels of anti-inflammatory cytokines (such as IL-4, -6, -8, and -13) and reducing inflammation through the PI3K/Akt/mTOR and/or TREM2 signalling pathways (<xref rid="B19" ref-type="bibr">Dai et al., 2017</xref>; <xref rid="B54" ref-type="bibr">Huang et al., 2022</xref>; <xref rid="B65" ref-type="bibr">Kaiser et al., 2022</xref>; <xref rid="B140" ref-type="bibr">Wu et al., 2024</xref>). Studies have also shown that TIIA-MSCs can significantly improve the learning and memory ability of A&#x003b2;<sub>25-35</sub> model rats and are more effective than MSCs. The protective mechanism may involve promoting the survival of hippocampal neurons by downregulating BACE1 expression and regulating neuroinflammation-related cytokines (<xref rid="B56" ref-type="bibr">Huang et al., 2019</xref>). In general, many studies have investigated the modification effect of Tan IIA on MSCs, but the specific mechanism of action of Tan IIA on MSC modification still needs further study.</p></sec><sec id="s3-5"><title>3.5 Astragaloside IV (AGS-IV)</title><p>AGS-IV is one of the main compounds of <italic>Astragalus membranaceus</italic> water extract and is a cycloartemisane-type triterpenoid glycoside chemical. Several studies have shown that AGS-IV has a strong protective effect on cardiovascular, lung, kidney, and brain-related diseases (<xref rid="B158" ref-type="bibr">Zhang et al., 2020</xref>). The pharmacological effects of AGS-IV are multifactorial and include anti-inflammatory effects via the inhibition of inflammatory factors, increased proliferation of T and B lymphocytes, and the inhibition of neutrophil adhesion-related molecules. Moreover, it has neuroprotective, antifibrotic and antitumour effects (<xref rid="B75" ref-type="bibr">Liang et al., 2023</xref>).</p><p>The ability of AGS-IV to modify MSCs is first reflected in the increased proliferative and paracrine activities of these cells. AGS-IV-treated ADSCs can significantly reverse the UV-B-induced decrease in PC-I secretion and increase MMP-1 release in fibroblasts. In addition, ASI-treated ADSCs significantly increased dermal thickness, collagen content, and microvascular density in the photoaged skin of nude mice (<xref rid="B98" ref-type="bibr">Niu et al., 2020</xref>). Second, AGS-IV has a positive effect on the cell cycle and osteogenic differentiation of MSCs. Studies have shown that AGS-IV can promote the activity of hBMSCs, the cell cycle, ALP activity and osteogenic differentiation through the miR-124-3p.1/STAT3 axis while increasing the expression of osteoblast marker molecules (<xref rid="B16" ref-type="bibr">Cao et al., 2021</xref>). Furthermore, AS-IV improved ADSC migration, angiogenesis, and endothelial recruitment. <italic>In vivo</italic>, AS-IV-pretreated ADSCs have greater angiogenesis potential and better therapeutic efficacy in ischaemic hindlimb models. The molecular mechanism may be related to the upregulation of CXCR2 to promote the phosphorylation of FAK (<xref rid="B134" ref-type="bibr">Wang et al., 2022</xref>). In contrast to other biological compounds, some studies have combined the modification effect of AGS-IV on MSCs with other biological compounds to explore the modification effect on MSCs. Studies have shown that the combination of tanshinone IIA and astragaloside IV can promote the proliferation and differentiation of MSCs. The mechanism may involve regulating the mobilization of MSCs by regulating the expression of CXCR4. Similarly, studies have shown that they can promote angiogenesis of endothelium-like cells by upregulating the expression of Cx37, Cx40 and Cx43 and enhancing the function of intercellular communication (<xref rid="B143" ref-type="bibr">Xie et al., 2013</xref>; <xref rid="B74" ref-type="bibr">Li et al., 2018</xref>).</p></sec><sec id="s3-6"><title>3.6 Curcumin</title><p>Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) is a phenolic natural product isolated from the roots of <italic>Curcuma longa L</italic>. Curcumin is reported to be a nutritional compound with a wide range of therapeutic effects and great medicinal potential. Curcumin has a variety of pharmacological effects, including anti-inflammatory, antioxidant, antiproliferative and antiangiogenic effects. It has been extensively studied in a variety of diseases, including cancer, cardiovascular disease, diabetes, arthritis, neurological diseases, and Crohn&#x02019;s disease (<xref rid="B33" ref-type="bibr">Genchi et al., 2024</xref>; <xref rid="B93" ref-type="bibr">Moon, 2024</xref>).</p><p>In terms of the ability of curcumin to modify MSCs, first, curcumin can slow the ageing of MSCs. Some studies have shown that curcumin can delay ageing by activating autophagy (<xref rid="B22" ref-type="bibr">Deng et al., 2021</xref>), and some studies have reported that its antiaging effect is related to its concentration. Curcumin at concentrations of 1 and 5&#x000a0;&#x000b5;M is a good antioxidant that can improve the lifespan of ASCs. The mechanism involves increasing the expression of the <italic>TERT</italic> gene (<xref rid="B102" ref-type="bibr">Pirmoradi et al., 2018</xref>). Second, curcumin can promote the osteogenic differentiation of BMSCs and inhibit the formation of adipocytes, which may be related to the expression of HO-1 (<xref rid="B37" ref-type="bibr">Gu et al., 2012</xref>). It has also been confirmed that curcumin can inhibit the expression of Kruppel-like Factor 15 (KLF15), which may bind to the PPAR&#x003b3; promoter, resulting in the downregulation of PPAR&#x003b3; expression to inhibit the lipid-forming differentiation of hMSCs. In addition, it can also protect the mitochondrial function of BMSCs. Moreover, it can improve the tolerance of ASCs to oxidative stress damage (<xref rid="B136" ref-type="bibr">Wang et al., 2019</xref>). The dual effects of curcumin on stem cell survival and proliferation are related to its concentration, treatment period and type of stem cells. Therefore, these results should be applied reasonably to aid in understanding the role of curcumin in the transformation of stem cells (<xref rid="B7" ref-type="bibr">Attari et al., 2015</xref>).</p></sec><sec id="s3-7"><title>3.7 Ginsenoside Rg1</title><p>Ginsenoside Rg1 belongs to the B-panaxtriol group of ginsenosides and is one of the main natural bioactive compounds of <italic>Panax ginseng</italic>. In traditional Chinese medicine, roots and rhizomes are the main medicinal parts of the plant. Rg1 ginsenosides are present in the stems, leaves and buds of <italic>P. ginseng</italic> and <italic>Panax notoginseng</italic> (<xref rid="B141" ref-type="bibr">Wu et al., 2022</xref>). In recent years, the pharmacological activity and bioavailability of ginsenoside Rg1 have been studied, and some new insights have been obtained (<xref rid="B31" ref-type="bibr">Gao et al., 2020</xref>; <xref rid="B84" ref-type="bibr">Lu et al., 2022</xref>). Ginsenoside Rg1 is a natural <italic>ginseng</italic> extract that has a variety of pharmacological effects, including anti-inflammatory, antioxidant and antiaging properties (<xref rid="B138" ref-type="bibr">Wang et al., 2021</xref>). The antiaging and antioxidant effects of Rg1 are related to the activation of the nuclear Factor E2-related Factor 2 (Nrf2) signalling pathway. Rg1 may activate the Nrf2 pathway by upregulating P62 and activating Akt to increase the interaction between P62 and KEAP1. Therefore, the activation of Akt or Nrf2 may be an important target for preventing BMSC ageing (<xref rid="B138" ref-type="bibr">Wang et al., 2021</xref>). In addition, studies have shown that Rg1 can reduce overactivation of the Wnt pathway in ageing cells by inhibiting the phosphorylation of GSK-3&#x003b2; and regulating the differentiation ability of MSCs (<xref rid="B137" ref-type="bibr">Wang et al., 2020</xref>). Rg1 can also promote the osteogenic differentiation of MSCs. Studies have shown that Rg1 can promote the osteogenic differentiation of BMSCs by activating the GR/BMP-2 signalling pathway (<xref rid="B39" ref-type="bibr">Gu et al., 2016</xref>). Other studies have shown that Rg1 can also induce the expression of cellular neurons, such as cells. The researchers cultured rat MSCs with the serum-free ginsenoside Rgl (10&#x000a0;&#x003bc;mol/L) for 3 days. Some of the cells expressed NSE, but GFAP staining was negative. The <italic>NGF</italic> mRNA level in the ginsenoside Rgl treatment group was significantly greater than that in the control group, suggesting that ginsenoside Rgl induced neuron-like cells to express <italic>NGF</italic> mRNA (<xref rid="B120" ref-type="bibr">Si et al., 2014</xref>).</p></sec><sec id="s3-8"><title>3.8 Thymoquinone (TQ)</title><p>
<italic>Nigella damascena L.</italic> is an annual herb in the <italic>Ranunculaceae</italic> family. TQ is the key active component of <italic>N. damascena L.</italic>, with a molecular formula of C<sub>10</sub>H<sub>12</sub>O<sub>2</sub> and a molar mass of 164.20&#x000a0;g/mol (<xref rid="B91" ref-type="bibr">Mekhemar et al., 2020</xref>). Its anti-inflammatory, antioxidant, antibacterial and anticancer properties have broad application prospects in biomedicine. TQ-mediated stimulation preserves the pluripotency of gingival mesenchymal stem cells/progenitors (G-MSCs) and promotes the transformation of these cells into immunocompetent differentiated phenotypes by increasing TLR3 expression. This characteristic may influence the potential therapeutic application of G-MSCs (<xref rid="B92" ref-type="bibr">Mekhemar et al., 2022</xref>). TQ can alter angiogenesis and the mesenchymal to epithelial transformation of human breast CSCs <italic>in vitro</italic>. Therefore, TQ, together with antiangiogenic therapy, may be a novel therapeutic agent to inhibit breast cancer angiogenesis (<xref rid="B41" ref-type="bibr">Haiaty et al., 2021a</xref>; <xref rid="B42" ref-type="bibr">Haiaty et al., 2021b</xref>).</p><p>Acute neurodegeneration due to stroke or trauma, for example, can lead to local cell damage in the injured area, whereas chronic neurodegeneration can lead to damage to specific subtypes of neurons and widespread loss of specific groups of neurons (<xref rid="B106" ref-type="bibr">Qin et al., 2007</xref>). Regenerating neurons by using stem cells seems to be a useful approach, as these cells can differentiate into multiple lineages (<xref rid="B85" ref-type="bibr">Lunn et al., 2011</xref>). The potential of stem cells to differentiate into neuronal lineages can be enhanced by the use of various compounds. TQ is a bioactive compound with neuroprotective properties (<xref rid="B59" ref-type="bibr">Ishaque et al., 2022</xref>). TQ was found to induce the differentiation of MSCs and promote significant gene expression of neuronal markers, including neuronal-specific enolase (NSE), nestin, microtubule-associated protein 2 (MAP2), neurofilament light chain (Nefl), and tau, as well as astrocyte markers, Glial fibrillary acidic protein (GFAP) (<xref rid="B59" ref-type="bibr">Ishaque et al., 2022</xref>). Similarly, studies have shown that TQ promotes the acceleration of stem cell differentiation into osteoblasts, the mechanism of which may be related to the inhibition of NF-&#x003ba;B signalling (<xref rid="B9" ref-type="bibr">Banu, 2022</xref>), and has been shown to not alter the physical and mechanical properties of the scaffold (<xref rid="B107" ref-type="bibr">Rahmani-Moghadam et al., 2021</xref>).</p></sec><sec id="s3-9"><title>3.9 Ptychotis verticillata (PV)</title><p>
<italic>Ptychotis verticillata L.</italic> is an aromatic plant, and PV and its phytochemical components (thymol and carvacrol) have been reported as valuable medicinal candidates (<xref rid="B27" ref-type="bibr">El Ouariachi el et al., 2011</xref>; <xref rid="B114" ref-type="bibr">Seo et al., 2019</xref>). Some studies have explored the effects of PV and its compounds on the immunological characteristics of MSCs. It was first emphasized that PV extracts can maintain low immunogenicity and enhance the immunomodulatory function of MSCs. The positive effects of the essential oils thymol and carvacrol on the immune properties of MSCs will open a new field for the use of natural compounds in cell therapy (<xref rid="B95" ref-type="bibr">Najar et al., 2024</xref>). Like many of the compounds mentioned earlier, thymol is also concentration dependent, and in the presence of thymol (3 and 6&#x000a0;&#x003bc;g/mL), MSCs show an increased ability to inhibit T-cell responses during direct coculture. High concentrations of thymol were more effective at reducing MSC-activated T-cell responses. The incubation time also affected the inhibitory properties of MSCs pretreated with thymol, as a small reduction was observed after 5&#x000a0;days. Based on this evidence, we aimed to study the effects of the characteristics of the MSC immune system, PV and its compounds (<xref rid="B95" ref-type="bibr">Najar et al., 2024</xref>). In addition, carvacrol and thymol have been shown to alter the maturation and function of dendritic cells, as well as the T-cell response and activation.</p><p>Different plant-derived components have been shown to promote MSC migration and homing to damaged sites to enhance tissue repair and healing. The activation of the PI3K and MAPK signalling pathways and the CXCL12/CXCR4 axis and the increased expression of matrix metalloproteinases (MMPs) may stimulate extracellular matrix remodelling, thereby promoting the migration of MSCs (<xref rid="B87" ref-type="bibr">Maeda, 2020</xref>). Other studies have shown that thymol and carvacrol increase osteogenesis and adipogenesis in a time- and dose-dependent manner and stimulate tissue regeneration and the repair function of MSCs, and further optimization of PV compound extraction and characterization and cell processing conditions should increase their therapeutic value in combination with MSCs (<xref rid="B13" ref-type="bibr">Bouhtit et al., 2022</xref>).</p></sec></sec><sec id="s4"><title>4 Regulatory effects of natural bioactive compounds on MSCs</title><p>Although many natural bioactive compounds have shown great potential for improving MSCs, they involve many mechanisms and pathways, making related research complicated and confusing. In fact, we found that natural bioactive compounds promote MSC proliferation, migration and homing and promote MSC differentiation and antiaging effects (<xref rid="F3" ref-type="fig">Figure 3</xref>). However, their effects can be guaranteed only under certain conditions. For example, although resveratrol can increase the self-renewal potential and pluripotency of early-passage MSCs, it also accelerates the senescence of late-passage MSCs. Therefore, cell passage and SIRT1 expression must be considered before resveratrol is used for late-passage MSCs (<xref rid="B150" ref-type="bibr">Yoon et al., 2015</xref>). In addition, the amount of naturally active compounds is also an important influencing factor; for example, 250&#x000a0;mg/kg/day is the most effective dose under the conditions where ICA has been shown to be beneficial to OP rats. However, ICA may inhibit the differentiation of MSCs into adipocytes by inhibiting the expression of <italic>PPAR&#x003b3;</italic>, <italic>C/EBP&#x003b1;</italic>, and <italic>FABP4</italic> mRNAs. ICA can also inhibit <italic>Notch2</italic> mRNA expression by inhibiting <italic>N1ICD</italic> expression. Therefore, further preclinical studies are needed to better define the pharmacological targets of ICA and to determine the associations between different signalling pathways (<xref rid="B78" ref-type="bibr">Liu et al., 2017</xref>). In the modification of MSCs by GBE, the key role of drug concentration was clearly proposed, and it was proposed that GBE improved the proliferation and osteogenesis of human BM-MSCs in a dose-dependent manner in the range of 25&#x02013;75&#x000a0;mg/L. However, this effect was weakened or inhibited at 100&#x000a0;mg/L or higher (<xref rid="B38" ref-type="bibr">Gu et al., 2015</xref>). In summary, natural bioactive compounds have complex and context-dependent effects on MSCs.</p><fig position="float" id="F3"><label>FIGURE 3</label><caption><p>Regulatory effects of bioactive compounds on MSCs. Natural bioactive compounds can promote the diffusion, migration, homing, differentiation and antiaging effects of MSCs.</p></caption><graphic xlink:href="fbioe-13-1446537-g003" position="float"/></fig><sec id="s4-1"><title>4.1 Promotion of proliferation, migration and homing</title><p>Although MSCs have various advantages and good applications in regenerative medicine, they are limited in the amount of tissue they target and have challenges associated with poor migration and homing. Therefore, it is worth exploring how to promote the proliferation, migration and homing of MSCs to play a better role in clinical practice (<xref rid="B30" ref-type="bibr">Galipeau and Sens&#x000e9;b&#x000e9;, 2018</xref>; <xref rid="B128" ref-type="bibr">Ullah et al., 2019</xref>). RSVL can play a positive role in the treatment of periodontitis by promoting the proliferation of MSCs (<xref rid="B62" ref-type="bibr">Jiang et al., 2023</xref>). Furthermore, AS-IV improved ADSC migration (<xref rid="B134" ref-type="bibr">Wang et al., 2022</xref>). <italic>In vivo</italic> animal experiments have confirmed that Rg1 promotes the homing of rabbit BMSCs to myocardial tissue (<xref rid="B133" ref-type="bibr">Wang et al., 2005</xref>). These changes reduced the myocardial infarct size and improved cardiac function. Some of them are obviously related to their concentration, so special attention should be given to this point when they are used (<xref rid="B38" ref-type="bibr">Gu et al., 2015</xref>).</p></sec><sec id="s4-2"><title>4.2 Promotion of differentiation</title><p>In some pathological conditions, such as ageing, osteoporosis and some bone defects, the osteogenic ability of BMSCs is significantly inhibited. Therefore, methods that can modulate the osteogenic differentiation of BMSCs to manage and treat these diseases are needed (<xref rid="B47" ref-type="bibr">Houdek et al., 2016</xref>; <xref rid="B162" ref-type="bibr">Zhang et al., 2021</xref>). In addition to RSVL, GBE, Tan IIA, and AGS-IV can promote the osteogenic differentiation of MSCs, as mentioned above, and studies have shown that walnut leaf extract regulates the osteogenic differentiation and autophagy of hBMSCs through the BMP2/Smad/Runx2 and Wnt/&#x003b2;-catenin pathways (<xref rid="B100" ref-type="bibr">Pang et al., 2022</xref>). Unlike the concentration dependence mentioned earlier, this study confirmed that different concentrations of walnut leaf extract did not have a significant effect on cell proliferation, indicating a reliable safety profile of hBMSCs treated with walnut leaf extract (<xref rid="B100" ref-type="bibr">Pang et al., 2022</xref>). Quercetin can activate the Wnt/&#x003b2;-catenin pathway through the H19/miR-625-5p axis and promote the osteogenic differentiation of BMSCs (<xref rid="B12" ref-type="bibr">Bian et al., 2021</xref>). In summary, various natural bioactive compounds have been demonstrated to enhance the differentiation of MSCs through distinct signalling pathways.</p></sec><sec id="s4-3"><title>4.3 Anti-aging</title><p>Cellular senescence is the result of cumulative changes in cellular structure and function. Its function manifests as reduced oxidative phosphorylation, a slowed respiratory rate, and reduced enzyme activity and receptor protein levels, resulting in decreased cell function and inhibited cell proliferation (<xref rid="B151" ref-type="bibr">Young et al., 2019</xref>). Studies have shown that senescent cells and the <italic>VDR</italic> gene expression interference system can reduce cell viability, proliferation and bone differentiation ability. MSCs inevitably encounter the problem of ageing, but studies have shown that after the addition of Astragalus, the viability and osteogenic ability of BMSCs are significantly increased. Among them, the expression levels of FGF23, Klotho and CYP24A1 decreased, whereas the expression level of CYP27B1 increased, and the effect became more obvious with increasing Astragalus concentration. It has been confirmed that astragalus can inhibit the ageing of BMSCs and improve their osteogenic ability by regulating the VD-FGF23-Klotho pathway (<xref rid="B105" ref-type="bibr">Pu et al., 2020</xref>). As mentioned earlier, curcumin can alleviate the ageing of BMSCs by activating autophagy, and curcumin is also a good antioxidant that can increase the lifespan of ASCs (<xref rid="B79" ref-type="bibr">Liu et al., 2015</xref>; <xref rid="B8" ref-type="bibr">Ayadilord et al., 2022</xref>). In summary, regulating ageing-related pathways and promoting autophagy are key to improving the effects of natural bioactive compounds on MSCs. The effects of natural bioactive compounds themselves, such as antioxidation, are the potential basis for these effects.</p></sec></sec><sec sec-type="discussion" id="s5"><title>5 Discussion</title><p>With the continuous development of cell therapy, researchers are striving to achieve the goal of effective repair and regeneration after tissue damage. The application of allogeneic human stem cells benefits from the immune tolerance of specific types of stem cells. In this context, the use of MSCs as promising tools for cellular immunotherapy is being explored for the treatment of a variety of diseases (<xref rid="B58" ref-type="bibr">Hussen et al., 2024</xref>). However, the clinical application of MSCs also faces many challenges. In the process of preparing MSC products, the main challenges include the following: 1) the heterogeneity of MSCs is caused by donor differences such as health status, genetics, gender and age. 2) The dry stability and differentiation ability of MSCs isolated from different sources (such as bone marrow, adipose tissue, the umbilical cord, or muscle) differ.3) The amplification ability was different under different culture conditions. In stem cell applications, the application of MSCs may be limited for the following reasons: 1) Challenges remain regarding the influence of the homing or migration ability of MSCs under different administration routes (local/systemic), injection sites, infusion times, and cell carrier materials. 2) Immunocompatibility between donors and recipients is key to reducing the risk of rejection. 3) The complex active components released by MSCs depend on the host microenvironment (inflammatory state, hypoxia, and ECM), which can lead to highly variable factors shaping the different functions of MSCs (<xref rid="B166" ref-type="bibr">Zhou et al., 2021</xref>). Therefore, improving the treatment efficiency of MSCs on the premise of ensuring safety, which has been discussed in the relevant literature (<xref rid="B114" ref-type="bibr">Seo et al., 2019</xref>), is imperative.</p><p>Natural bioactive compounds such as RSVL, GBE and curcumin can regulate the survival and proliferation of MSCs, but their effects on proliferation are closely related to their concentration, so caution should be taken. ICA and RSVL can promote osteogenic differentiation and inhibit lipid differentiation via different mechanisms, and research on nonbone tissue differentiation is insufficient. Tan IIA and AGS-IV can promote MSC migration and homing, but few relevant studies exist. Curcumin and Rg1 can inhibit MSC ageing, but such studies are scarce. These compounds have multitarget and multilevel effects, have different effects on the improvement of MSCs, and may receive more attention in the future.</p><p>Although the effects of many bioactive compounds on MSCs have been discussed above, several issues warrant attention. For example, not all concentrations of bioactive compounds can positively modify MSCs, and they are not all concentration dependent; each has its own characteristics. In addition, relatively few <italic>in vivo</italic> experiments have investigated the effects of natural bioactive compounds on MSCs, which may be the direction of our attention in the future. Moreover, another challenge is that most of the natural bioactive compounds mentioned in the literature are only 98% or 99% pure. However, their application in the field of stem cell research is promising, and we hope to further identify their purity, remove impurities, and achieve better promotion and application of these compounds in the future (<xref rid="B73" ref-type="bibr">Li et al., 2024</xref>).</p></sec><sec sec-type="conclusion" id="s6"><title>6 Conclusion</title><p>Different types of natural bioactive compounds have different effects on the improvement of MSCs, such as promoting their proliferation and differentiation, migration and homing, and antiaging effects. It is expected that improved MSCs can provide new ideas for disease treatment and regenerative medicine in the future.</p></sec></body><back><sec sec-type="author-contributions" id="s7"><title>Author contributions</title><p>JW: Funding acquisition, Writing &#x02013; original draft, Writing &#x02013; review and editing. YG: Writing &#x02013; review and editing. WH: Writing &#x02013; review and editing. LZ: Writing &#x02013; review and editing. JH: Conceptualization, Funding acquisition, Writing &#x02013; review and editing. NH: Conceptualization, Funding acquisition, Writing &#x02013; review and editing. YL: Conceptualization, Funding acquisition, Writing &#x02013; review and editing.</p></sec><sec sec-type="COI-statement" id="s9"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="s10"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abbott</surname><given-names>A.</given-names></name></person-group> (<year>2025</year>). <article-title>Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson's disease could soon be here</article-title>. <source>Nature</source>
<volume>637</volume> (<issue>8044</issue>), <fpage>18</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1038/d41586-024-04160-0</pub-id>
<pub-id pub-id-type="pmid">39707007</pub-id>
</mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Al-Azab</surname><given-names>M.</given-names></name><name><surname>Idiiatullina</surname><given-names>E.</given-names></name><name><surname>Safi</surname><given-names>M.</given-names></name><name><surname>Hezam</surname><given-names>K.</given-names></name></person-group> (<year>2023</year>). <article-title>Enhancers of mesenchymal stem cell stemness and therapeutic potency</article-title>. <source>Biomed. Pharmacother.</source>
<volume>162</volume>, <fpage>114356</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2023.114356</pub-id>
<pub-id pub-id-type="pmid">37040673</pub-id>
</mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Al-Azab</surname><given-names>M.</given-names></name><name><surname>Safi</surname><given-names>M.</given-names></name><name><surname>Idiiatullina</surname><given-names>E.</given-names></name><name><surname>Al-Shaebi</surname><given-names>F.</given-names></name><name><surname>Zaky</surname><given-names>M. Y.</given-names></name></person-group> (<year>2022</year>). <article-title>Aging of mesenchymal stem cell: machinery, markers, and strategies of fighting</article-title>. <source>Cell Mol. Biol. Lett.</source>
<volume>27</volume> (<issue>1</issue>), <fpage>69</fpage>. <pub-id pub-id-type="doi">10.1186/s11658-022-00366-0</pub-id>
<pub-id pub-id-type="pmid">35986247</pub-id>
</mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Al-Ghadban</surname><given-names>S.</given-names></name><name><surname>Artiles</surname><given-names>M.</given-names></name><name><surname>Bunnell</surname><given-names>B. A.</given-names></name></person-group> (<year>2022</year>). <article-title>Adipose stem cells in regenerative medicine: looking forward</article-title>. <source>Front. Bioeng. Biotechnol.</source>
<volume>9</volume>, <fpage>837464</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2021.837464</pub-id>
<pub-id pub-id-type="pmid">35096804</pub-id>
</mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Al-Sammarraie</surname><given-names>S. H. A.</given-names></name><name><surname>Ayaz-G&#x000fc;ner</surname><given-names>&#x0015e;.</given-names></name><name><surname>Acar</surname><given-names>M. B.</given-names></name><name><surname>&#x0015e;im&#x0015f;ek</surname><given-names>A.</given-names></name><name><surname>S&#x00131;n&#x00131;ksaran</surname><given-names>B. S.</given-names></name><name><surname>Bozalan</surname><given-names>H. D.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Mesenchymal stem cells from adipose tissue prone to lose their stemness associated markers in obesity related stress conditions</article-title>. <source>Sci. Rep.</source>
<volume>14</volume> (<issue>1</issue>), <fpage>19702</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-024-70127-w</pub-id>
<pub-id pub-id-type="pmid">39181924</pub-id>
</mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ansari</surname><given-names>M. A.</given-names></name><name><surname>Khan</surname><given-names>F. B.</given-names></name><name><surname>Safdari</surname><given-names>H. A.</given-names></name><name><surname>Almatroudi</surname><given-names>A.</given-names></name><name><surname>Alzohairy</surname><given-names>M. A.</given-names></name><name><surname>Safdari</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Prospective therapeutic potential of Tanshinone IIA: an updated overview</article-title>. <source>Pharmacol. Res.</source>
<volume>164</volume>, <fpage>105364</fpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2020.105364</pub-id>
<pub-id pub-id-type="pmid">33285229</pub-id>
</mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Attari</surname><given-names>F.</given-names></name><name><surname>Zahmatkesh</surname><given-names>M.</given-names></name><name><surname>Aligholi</surname><given-names>H.</given-names></name><name><surname>Mehr</surname><given-names>S. E.</given-names></name><name><surname>Sharifzadeh</surname><given-names>M.</given-names></name><name><surname>Gorji</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Curcumin as a double-edged sword for stem cells: dose, time and cell type-specific responses to curcumin</article-title>. <source>Daru</source>
<volume>23</volume> (<issue>1</issue>), <fpage>33</fpage>. <pub-id pub-id-type="doi">10.1186/s40199-015-0115-8</pub-id>
<pub-id pub-id-type="pmid">26063234</pub-id>
</mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ayadilord</surname><given-names>M.</given-names></name><name><surname>Saharkhiz</surname><given-names>M.</given-names></name><name><surname>Naseri</surname><given-names>M.</given-names></name><name><surname>Emadian Razavi</surname><given-names>F.</given-names></name></person-group> (<year>2022</year>). <article-title>Expression of immunomodulatory and tissue regenerative biomarkers in human dental pulp derived-mesenchymal stem cells treated with curcumin: an <italic>in vitro</italic> study</article-title>. <source>Mol. Biol. Rep.</source>
<volume>49</volume> (<issue>6</issue>), <fpage>4411</fpage>&#x02013;<lpage>4420</lpage>. <pub-id pub-id-type="doi">10.1007/s11033-022-07278-4</pub-id>
<pub-id pub-id-type="pmid">35301656</pub-id>
</mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Banu</surname><given-names>I.</given-names></name></person-group> (<year>2022</year>). <article-title>The active compound thymoquinone alters chondrogenic differentiation of human mesenchymal stem cells via modulation of intracellular signaling</article-title>. <source>Medeni. Med. J.</source>
<volume>37</volume> (<issue>1</issue>), <fpage>1</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.4274/MMJ.galenos.2022.68915</pub-id>
<pub-id pub-id-type="pmid">35306780</pub-id>
</mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barone</surname><given-names>L.</given-names></name><name><surname>Palano</surname><given-names>M. T.</given-names></name><name><surname>Gallazzi</surname><given-names>M.</given-names></name><name><surname>Cucchiara</surname><given-names>M.</given-names></name><name><surname>Rossi</surname><given-names>F.</given-names></name><name><surname>Borgese</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Adipose mesenchymal stem cell-derived soluble factors, produced under hypoxic condition, efficiently support <italic>in vivo</italic> angiogenesis</article-title>. <source>Cell Death Discov.</source>
<volume>9</volume> (<issue>1</issue>), <fpage>174</fpage>. <pub-id pub-id-type="doi">10.1038/s41420-023-01464-4</pub-id>
<pub-id pub-id-type="pmid">37221171</pub-id>
</mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bi</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Yan</surname><given-names>X.</given-names></name></person-group> (<year>2022</year>). <article-title>Anti-inflammatory and immunoregulatory effects of icariin and icaritin</article-title>. <source>Biomed. Pharmacother.</source>
<volume>151</volume>, <fpage>113180</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2022.113180</pub-id>
<pub-id pub-id-type="pmid">35676785</pub-id>
</mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bian</surname><given-names>W.</given-names></name><name><surname>Xiao</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Deng</surname><given-names>S.</given-names></name></person-group> (<year>2021</year>). <article-title>Quercetin promotes bone marrow mesenchymal stem cell proliferation and osteogenic differentiation through the H19/miR-625-5p axis to activate the Wnt/&#x003b2;-catenin pathway</article-title>. <source>BMC Complement. Med. Ther.</source>
<volume>21</volume> (<issue>1</issue>), <fpage>243</fpage>. <pub-id pub-id-type="doi">10.1186/s12906-021-03418-8</pub-id>
<pub-id pub-id-type="pmid">34592982</pub-id>
</mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bouhtit</surname><given-names>F.</given-names></name><name><surname>Najar</surname><given-names>M.</given-names></name><name><surname>Rahmani</surname><given-names>S.</given-names></name><name><surname>Melki</surname><given-names>R.</given-names></name><name><surname>Najimi</surname><given-names>M.</given-names></name><name><surname>Sadki</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Bioscreening and pre-clinical evaluation of the impact of bioactive molecules from Ptychotis verticillata on the multilineage potential of mesenchymal stromal cells towards immune- and inflammation-mediated diseases</article-title>. <source>Inflamm. Res.</source>
<volume>71</volume> (<issue>7-8</issue>), <fpage>887</fpage>&#x02013;<lpage>898</lpage>. <pub-id pub-id-type="doi">10.1007/s00011-022-01573-3</pub-id>
<pub-id pub-id-type="pmid">35716172</pub-id>
</mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Caldarelli</surname><given-names>I.</given-names></name><name><surname>Speranza</surname><given-names>M. C.</given-names></name><name><surname>Bencivenga</surname><given-names>D.</given-names></name><name><surname>Tramontano</surname><given-names>A.</given-names></name><name><surname>Borgia</surname><given-names>A.</given-names></name><name><surname>Pirozzi</surname><given-names>A. V.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Resveratrol mimics insulin activity in the adipogenic commitment of human bone marrow mesenchymal stromal cells</article-title>. <source>Int. J. Biochem. Cell Biol.</source>
<volume>60</volume>, <fpage>60</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2014.12.011</pub-id>
<pub-id pub-id-type="pmid">25562512</pub-id>
</mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Boss</surname><given-names>A. L.</given-names></name><name><surname>Bolam</surname><given-names>S. M.</given-names></name><name><surname>Munro</surname><given-names>J. T.</given-names></name><name><surname>Crawford</surname><given-names>H.</given-names></name><name><surname>Dalbeth</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>
<italic>In vitro</italic> cell surface marker expression on mesenchymal stem cell cultures does not reflect their <italic>ex vivo</italic> phenotype</article-title>. <source>Stem Cell Rev. Rep.</source>
<volume>20</volume> (<issue>6</issue>), <fpage>1656</fpage>&#x02013;<lpage>1666</lpage>. <pub-id pub-id-type="doi">10.1007/s12015-024-10743-1</pub-id>
<pub-id pub-id-type="pmid">38837115</pub-id>
</mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Lv</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group> (<year>2021</year>). <article-title>Astragaloside IV improves tibial defect in rats and promotes proliferation and osteogenic differentiation of hBMSCs through MiR-124-3p.1/STAT3 Axis</article-title>. <source>J. Nat. Prod.</source>
<volume>84</volume> (<issue>2</issue>), <fpage>287</fpage>&#x02013;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.0c00975</pub-id>
<pub-id pub-id-type="pmid">33464097</pub-id>
</mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cawthorn</surname><given-names>W. P.</given-names></name><name><surname>Scheller</surname><given-names>E. L.</given-names></name><name><surname>MacDougald</surname><given-names>O. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Adipose tissue stem cells: the great WAT hope</article-title>. <source>Trends Endocrinol. Metab.</source>
<volume>23</volume> (<issue>6</issue>), <fpage>270</fpage>&#x02013;<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1016/j.tem.2012.01.003</pub-id>
<pub-id pub-id-type="pmid">22417866</pub-id>
</mixed-citation></ref><ref id="B171"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Liang</surname><given-names>H.</given-names></name><name><surname>Ji</surname><given-names>Y.</given-names></name><name><surname>Kou</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Shang</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Curcumin Modulates the Crosstalk Between Macrophages and Bone Mesenchymal Stem Cells to Ameliorate Osteogenesis[J]</article-title>. <source>Front. Cell. Dev. Biol.</source>
<volume>9</volume>, <fpage>634650</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2021.634650</pub-id>
<pub-id pub-id-type="pmid">33634135</pub-id>
</mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>Z. X.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Wen</surname><given-names>W.</given-names></name><name><surname>Schaniel</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Reprogramming of human peripheral blood mononuclear cells into induced mesenchymal stromal cells using non-integrating vectors</article-title>. <source>Commun. Biol.</source>
<volume>6</volume> (<issue>1</issue>), <fpage>393</fpage>. <pub-id pub-id-type="doi">10.1038/s42003-023-04737-x</pub-id>
<pub-id pub-id-type="pmid">37041280</pub-id>
</mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dai</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Dong</surname><given-names>Z.</given-names></name></person-group> (<year>2017</year>). <article-title>Tanshinone I alleviates motor and cognitive impairments via suppressing oxidative stress in the neonatal rats after hypoxic-ischemic brain damage</article-title>. <source>Mol. Brain</source>
<volume>10</volume> (<issue>1</issue>), <fpage>52</fpage>. <pub-id pub-id-type="doi">10.1186/s13041-017-0332-9</pub-id>
<pub-id pub-id-type="pmid">29137683</pub-id>
</mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dai</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Quarles</surname><given-names>L. D.</given-names></name><name><surname>Song</surname><given-names>T.</given-names></name><name><surname>Pan</surname><given-names>W.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation</article-title>. <source>Phytomedicine</source>
<volume>14</volume> (<issue>12</issue>), <fpage>806</fpage>&#x02013;<lpage>814</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2007.04.003</pub-id>
<pub-id pub-id-type="pmid">17689939</pub-id>
</mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Daneshmandi</surname><given-names>L.</given-names></name><name><surname>Shah</surname><given-names>S.</given-names></name><name><surname>Jafari</surname><given-names>T.</given-names></name><name><surname>Bhattacharjee</surname><given-names>M.</given-names></name><name><surname>Momah</surname><given-names>D.</given-names></name><name><surname>Saveh-Shemshaki</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Emergence of the stem cell secretome in regenerative engineering</article-title>. <source>Trends Biotechnol.</source>
<volume>38</volume> (<issue>12</issue>), <fpage>1373</fpage>&#x02013;<lpage>1384</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2020.04.013</pub-id>
<pub-id pub-id-type="pmid">32622558</pub-id>
</mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Deng</surname><given-names>J.</given-names></name><name><surname>Ouyang</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Zhong</surname><given-names>L.</given-names></name><name><surname>Gu</surname><given-names>C.</given-names></name><name><surname>Shen</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Curcumin alleviates the senescence of canine bone marrow mesenchymal stem cells during <italic>in vitro</italic> expansion by activating the autophagy pathway</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>22</volume> (<issue>21</issue>), <fpage>11356</fpage>. <pub-id pub-id-type="doi">10.3390/ijms222111356</pub-id>
<pub-id pub-id-type="pmid">34768788</pub-id>
</mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ding</surname><given-names>M.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Xie</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Exosomes isolated from human umbilical cord mesenchymal stem cells alleviate neuroinflammation and reduce amyloid-beta deposition by modulating microglial activation in Alzheimer's disease</article-title>. <source>Neurochem. Res.</source>
<volume>43</volume> (<issue>11</issue>), <fpage>2165</fpage>&#x02013;<lpage>2177</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-018-2641-5</pub-id>
<pub-id pub-id-type="pmid">30259257</pub-id>
</mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Doktor</surname><given-names>F.</given-names></name><name><surname>Antounians</surname><given-names>L.</given-names></name><name><surname>Figueira</surname><given-names>R. L.</given-names></name><name><surname>Khalaj</surname><given-names>K.</given-names></name><name><surname>Duci</surname><given-names>M.</given-names></name><name><surname>Zani</surname><given-names>A.</given-names></name></person-group> (<year>2025</year>). <article-title>Amniotic fluid stem cell extracellular vesicles as a novel fetal therapy for pulmonary hypoplasia: a review on mechanisms and translational potential</article-title>. <source>Stem Cells Transl. Med.</source>
<volume>14</volume> (<issue>1</issue>), <fpage>szae095</fpage>. <pub-id pub-id-type="doi">10.1093/stcltm/szae095</pub-id>
<pub-id pub-id-type="pmid">39823257</pub-id>
</mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eirin</surname><given-names>A.</given-names></name><name><surname>Thaler</surname><given-names>R.</given-names></name><name><surname>Glasstetter</surname><given-names>L. M.</given-names></name><name><surname>Xing</surname><given-names>L.</given-names></name><name><surname>Zhu</surname><given-names>X. Y.</given-names></name><name><surname>Osborne</surname><given-names>A. C.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Obesity-driven mitochondrial dysfunction in human adipose tissue-derived mesenchymal stem/stromal cells involves epigenetic changes</article-title>. <source>Cell Death Dis.</source>
<volume>15</volume> (<issue>6</issue>), <fpage>387</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-024-06774-8</pub-id>
<pub-id pub-id-type="pmid">38824145</pub-id>
</mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eiro</surname><given-names>N.</given-names></name><name><surname>Fraile</surname><given-names>M.</given-names></name><name><surname>Escudero-Cernuda</surname><given-names>S.</given-names></name><name><surname>Sendon-Lago</surname><given-names>J.</given-names></name><name><surname>Gonzalez</surname><given-names>L. O.</given-names></name><name><surname>Fernandez-S&#x000e1;nchez</surname><given-names>M. L.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Synergistic effect of human uterine cervical mesenchymal stem cell secretome and paclitaxel on triple negative breast cancer</article-title>. <source>Stem Cell Res. Ther.</source>
<volume>15</volume> (<issue>1</issue>), <fpage>121</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-024-03717-0</pub-id>
<pub-id pub-id-type="pmid">38664697</pub-id>
</mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>El Ouariachi el</surname><given-names>M.</given-names></name><name><surname>Tomi</surname><given-names>P.</given-names></name><name><surname>Bouyanzer</surname><given-names>A.</given-names></name><name><surname>Hammouti</surname><given-names>B.</given-names></name><name><surname>Desjobert</surname><given-names>J. M.</given-names></name><name><surname>Costa</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Chemical composition and antioxidant activity of essential oils and solvent extracts of Ptychotis verticillata from Morocco</article-title>. <source>Food Chem. Toxicol.</source>
<volume>49</volume> (<issue>2</issue>), <fpage>533</fpage>&#x02013;<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2010.11.019</pub-id>
<pub-id pub-id-type="pmid">21093522</pub-id>
</mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Feng</surname><given-names>J.</given-names></name><name><surname>Liao</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name></person-group> (<year>2022</year>). <article-title>Combination of stem cells with Chinese herbs for secondary depression in neurodegenerative diseases based on traditional Chinese medicine theories</article-title>. <source>Evid. Based Complement. Altern. Med.</source>
<volume>2022</volume>, <fpage>1</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1155/2022/6847917</pub-id>
</mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fu</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>G.</given-names></name><name><surname>Halim</surname><given-names>A.</given-names></name><name><surname>Ju</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>Q.</given-names></name><name><surname>Song</surname><given-names>A. G.</given-names></name></person-group> (<year>2019</year>). <article-title>Mesenchymal stem cell migration and tissue repair</article-title>. <source>Cells</source>
<volume>8</volume> (<issue>8</issue>), <fpage>784</fpage>. <pub-id pub-id-type="doi">10.3390/cells8080784</pub-id>
<pub-id pub-id-type="pmid">31357692</pub-id>
</mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Galipeau</surname><given-names>J.</given-names></name><name><surname>Sens&#x000e9;b&#x000e9;</surname><given-names>L.</given-names></name></person-group> (<year>2018</year>). <article-title>Mesenchymal stromal cells: clinical challenges and therapeutic opportunities</article-title>. <source>Cell Stem Cell</source>
<volume>22</volume> (<issue>6</issue>), <fpage>824</fpage>&#x02013;<lpage>833</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2018.05.004</pub-id>
<pub-id pub-id-type="pmid">29859173</pub-id>
</mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Chu</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Ginsenoside Rg1 prevent and treat inflammatory diseases: a review</article-title>. <source>Int. Immunopharmacol.</source>
<volume>87</volume>, <fpage>106805</fpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2020.106805</pub-id>
<pub-id pub-id-type="pmid">32731179</pub-id>
</mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ge</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>N.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name></person-group> (<year>2024</year>). <article-title>A new strategy for the regulation of neuroinflammation: exosomes derived from mesenchymal stem cells</article-title>. <source>Cell Mol. Neurobiol.</source>
<volume>44</volume> (<issue>1</issue>), <fpage>24</fpage>. <pub-id pub-id-type="doi">10.1007/s10571-024-01460-x</pub-id>
<pub-id pub-id-type="pmid">38372822</pub-id>
</mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Genchi</surname><given-names>G.</given-names></name><name><surname>Lauria</surname><given-names>G.</given-names></name><name><surname>Catalano</surname><given-names>A.</given-names></name><name><surname>Carocci</surname><given-names>A.</given-names></name><name><surname>Sinicropi</surname><given-names>M. S.</given-names></name></person-group> (<year>2024</year>). <article-title>Neuroprotective effects of curcumin in neurodegenerative diseases</article-title>. <source>Neurodegener. Dis.</source>
<volume>13</volume> (<issue>11</issue>), <fpage>1774</fpage>. <pub-id pub-id-type="doi">10.3390/foods13111774</pub-id>
</mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Geng</surname><given-names>Y. W.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>M. Y.</given-names></name><name><surname>Hu</surname><given-names>W. P.</given-names></name></person-group> (<year>2017</year>). <article-title>Differentiation of human dental pulp stem cells into neuronal by resveratrol</article-title>. <source>Cell Biol. Int.</source>
<volume>41</volume> (<issue>12</issue>), <fpage>1391</fpage>&#x02013;<lpage>1398</lpage>. <pub-id pub-id-type="doi">10.1002/cbin.10835</pub-id>
<pub-id pub-id-type="pmid">28782906</pub-id>
</mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gopalarethinam</surname><given-names>J.</given-names></name><name><surname>Nair</surname><given-names>A. P.</given-names></name><name><surname>Iyer</surname><given-names>M.</given-names></name><name><surname>Vellingiri</surname><given-names>B.</given-names></name><name><surname>Subramaniam</surname><given-names>M. D.</given-names></name></person-group> (<year>2023</year>). <article-title>Advantages of mesenchymal stem cell over the other stem cells</article-title>. <source>Acta histochem.</source>
<volume>125</volume> (<issue>4</issue>), <fpage>152041</fpage>. <pub-id pub-id-type="doi">10.1016/j.acthis.2023.152041</pub-id>
<pub-id pub-id-type="pmid">37167794</pub-id>
</mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gou</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>P.</given-names></name><name><surname>Zhong</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Adipose-derived mesenchymal stem cells (MSCs) are a superior cell source for bone tissue engineering</article-title>. <source>Bioact. Mater</source>
<volume>34</volume>, <fpage>51</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.bioactmat.2023.12.003</pub-id>
<pub-id pub-id-type="pmid">38186960</pub-id>
</mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gu</surname><given-names>Q.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Shi</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name></person-group> (<year>2012</year>). <article-title>Curcumin increases rat mesenchymal stem cell osteoblast differentiation but inhibits adipocyte differentiation</article-title>. <source>Pharmacogn. Mag.</source>
<volume>8</volume> (<issue>31</issue>), <fpage>202</fpage>&#x02013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.4103/0973-1296.99285</pub-id>
<pub-id pub-id-type="pmid">23060694</pub-id>
</mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gu</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Fan</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Ginkgo biloba extract promotes osteogenic differentiation of human bone marrow mesenchymal stem cells in a pathway involving Wnt/&#x003b2;-catenin signaling</article-title>. <source>Pharmacol. Res.</source>
<volume>97</volume>, <fpage>70</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2015.04.004</pub-id>
<pub-id pub-id-type="pmid">25917209</pub-id>
</mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gu</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Fan</surname><given-names>W.</given-names></name><name><surname>Yin</surname><given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Ginsenoside Rg1 promotes osteogenic differentiation of rBMSCs and healing of rat tibial fractures through regulation of GR-dependent BMP-2/SMAD signaling</article-title>. <source>Sci. Rep.</source>
<volume>6</volume>, <fpage>25282</fpage>. <pub-id pub-id-type="doi">10.1038/srep25282</pub-id>
<pub-id pub-id-type="pmid">27141994</pub-id>
</mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gugliandolo</surname><given-names>A.</given-names></name><name><surname>Bramanti</surname><given-names>P.</given-names></name><name><surname>Mazzon</surname><given-names>E.</given-names></name></person-group> (<year>2020</year>). <article-title>Activation of Nrf2 by natural bioactive compounds: a promising approach for stroke?</article-title>
<source>Int. J. Mol. Sci.</source>
<volume>21</volume> (<issue>14</issue>), <fpage>4875</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21144875</pub-id>
<pub-id pub-id-type="pmid">32664226</pub-id>
</mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haiaty</surname><given-names>S.</given-names></name><name><surname>Rashidi</surname><given-names>M. R.</given-names></name><name><surname>Akbarzadeh</surname><given-names>M.</given-names></name><name><surname>Bazmani</surname><given-names>A.</given-names></name><name><surname>Mostafazadeh</surname><given-names>M.</given-names></name><name><surname>Nikanfar</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2021a</year>). <article-title>Correction to: thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells</article-title>. <source>BMC Complement. Med. Ther.</source>
<volume>21</volume> (<issue>1</issue>), <fpage>266</fpage>. <pub-id pub-id-type="doi">10.1186/s12906-021-03414-y</pub-id>
<pub-id pub-id-type="pmid">34696750</pub-id>
</mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haiaty</surname><given-names>S.</given-names></name><name><surname>Rashidi</surname><given-names>M. R.</given-names></name><name><surname>Akbarzadeh</surname><given-names>M.</given-names></name><name><surname>Bazmani</surname><given-names>A.</given-names></name><name><surname>Mostafazadeh</surname><given-names>M.</given-names></name><name><surname>Nikanfar</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2021b</year>). <article-title>Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells</article-title>. <source>BMC Complement. Med. Ther.</source>
<volume>21</volume> (<issue>1</issue>), <fpage>83</fpage>. <pub-id pub-id-type="doi">10.1186/s12906-021-03246-w</pub-id>
<pub-id pub-id-type="pmid">33663486</pub-id>
</mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Han</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>B. T.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Xing</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Engineered stem cell-based strategy: a new paradigm of next-generation stem cell product in regenerative medicine</article-title>. <source>J. Control Release</source>
<volume>365</volume>, <fpage>981</fpage>&#x02013;<lpage>1003</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2023.12.024</pub-id>
<pub-id pub-id-type="pmid">38123072</pub-id>
</mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Han</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Fang</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Candi</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>The secretion profile of mesenchymal stem cells and potential applications in treating human diseases</article-title>. <source>Signal Transduct. Target Ther.</source>
<volume>7</volume> (<issue>1</issue>), <fpage>92</fpage>. <pub-id pub-id-type="doi">10.1038/s41392-022-00932-0</pub-id>
<pub-id pub-id-type="pmid">35314676</pub-id>
</mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hazrati</surname><given-names>A.</given-names></name><name><surname>Malekpour</surname><given-names>K.</given-names></name><name><surname>Khorramdelazad</surname><given-names>H.</given-names></name><name><surname>Rajaei</surname><given-names>S.</given-names></name><name><surname>Hashemi</surname><given-names>S. M.</given-names></name></person-group> (<year>2024</year>). <article-title>Therapeutic and immunomodulatory potentials of mesenchymal stromal/stem cells and immune checkpoints related molecules</article-title>. <source>Biomark. Res.</source>
<volume>12</volume> (<issue>1</issue>), <fpage>35</fpage>. <pub-id pub-id-type="doi">10.1186/s40364-024-00580-2</pub-id>
<pub-id pub-id-type="pmid">38515166</pub-id>
</mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name></person-group> (<year>2020</year>). <article-title>Pharmacological effects of icariin</article-title>. <source>Adv. Pharmacol.</source>
<volume>87</volume>, <fpage>179</fpage>&#x02013;<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1016/bs.apha.2019.10.004</pub-id>
<pub-id pub-id-type="pmid">32089233</pub-id>
</mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Houdek</surname><given-names>M. T.</given-names></name><name><surname>Wyles</surname><given-names>C. C.</given-names></name><name><surname>Packard</surname><given-names>B. D.</given-names></name><name><surname>Terzic</surname><given-names>A.</given-names></name><name><surname>Behfar</surname><given-names>A.</given-names></name><name><surname>Sierra</surname><given-names>R. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Decreased osteogenic activity of mesenchymal stem cells in patients with corticosteroid-induced osteonecrosis of the femoral head</article-title>. <source>J. Arthroplasty</source>
<volume>31</volume> (<issue>4</issue>), <fpage>893</fpage>&#x02013;<lpage>898</lpage>. <pub-id pub-id-type="doi">10.1016/j.arth.2015.08.017</pub-id>
<pub-id pub-id-type="pmid">26404846</pub-id>
</mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>T. P.</given-names></name><name><surname>Sheu</surname><given-names>S. Y.</given-names></name><name><surname>Sun</surname><given-names>J. S.</given-names></name><name><surname>Chen</surname><given-names>M. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-&#x003ba;B regulated HIF-1&#x003b1; and PGE(2) synthesis</article-title>. <source>Phytomedicine</source>
<volume>18</volume> (<issue>2-3</issue>), <fpage>176</fpage>&#x02013;<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2010.04.003</pub-id>
<pub-id pub-id-type="pmid">20554188</pub-id>
</mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name></person-group> (<year>2019</year>). <article-title>The application of resveratrol to mesenchymal stromal cell-based regenerative medicine</article-title>. <source>Stem Cell Res. Ther.</source>
<volume>10</volume> (<issue>1</issue>), <fpage>307</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-019-1412-9</pub-id>
<pub-id pub-id-type="pmid">31623691</pub-id>
</mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>H. J.</given-names></name><name><surname>Yu</surname><given-names>L. H.</given-names></name><name><surname>Guan</surname><given-names>Z. R.</given-names></name><name><surname>Jiang</surname><given-names>Y. P.</given-names></name><name><surname>Hu</surname><given-names>J. H.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>The role of Ginkgo Folium on antitumor: bioactive constituents and the potential mechanism</article-title>. <source>J. Ethnopharmacol.</source>
<volume>321</volume>, <fpage>117202</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2023.117202</pub-id>
<pub-id pub-id-type="pmid">37742878</pub-id>
</mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>N.</given-names></name><name><surname>Mao</surname><given-names>Q.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Qiu</surname><given-names>Y.</given-names></name></person-group> (<year>2023</year>). <article-title>Natural bioactive compounds in Alzheimer's disease: from the perspective of type 3 diabetes mellitus</article-title>. <source>Front. Aging Neurosci.</source>
<volume>15</volume>, <fpage>1130253</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2023.1130253</pub-id>
<pub-id pub-id-type="pmid">37009462</pub-id>
</mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>N.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Jin</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Signaling mechanisms underlying inhibition of neuroinflammation by resveratrol in neurodegenerative diseases</article-title>. <source>J. Nutr. Biochem.</source>
<volume>88</volume>, <fpage>108552</fpage>. <pub-id pub-id-type="doi">10.1016/j.jnutbio.2020.108552</pub-id>
<pub-id pub-id-type="pmid">33220405</pub-id>
</mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>J. M.</given-names></name><name><surname>Bao</surname><given-names>Y.</given-names></name><name><surname>Xiang</surname><given-names>W.</given-names></name><name><surname>Jing</surname><given-names>X. Z.</given-names></name><name><surname>Guo</surname><given-names>J. C.</given-names></name><name><surname>Yao</surname><given-names>X. D.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Icariin regulates the bidirectional differentiation of bone marrow mesenchymal stem cells through canonical Wnt signaling pathway</article-title>. <source>Evid. Based Complement. Altern. Med.</source>
<volume>2017</volume>, <fpage>8085325</fpage>. <pub-id pub-id-type="doi">10.1155/2017/8085325</pub-id>
</mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>N.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>F.</given-names></name><name><surname>Ba</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name></person-group> (<year>2022</year>). <article-title>Tanshinone &#x00399;&#x00399;A-incubated mesenchymal stem cells inhibit lipopolysaccharide-induced inflammation of N9 cells through TREM2 signaling pathway</article-title>. <source>Stem Cells Int.</source>
<volume>2022</volume>, <fpage>1</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1155/2022/9977610</pub-id>
</mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>N.</given-names></name><name><surname>Huang</surname><given-names>W.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Long</surname><given-names>S.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name></person-group> (<year>2024</year>). <article-title>Possible opportunities and challenges for traditional Chinese medicine research in 2035</article-title>. <source>Front. Pharmacol.</source>
<volume>15</volume>, <fpage>1426300</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2024.1426300</pub-id>
<pub-id pub-id-type="pmid">38974044</pub-id>
</mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Feng</surname><given-names>F.</given-names></name><name><surname>Shi</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Neuroprotective effect of tanshinone IIA-incubated mesenchymal stem cells on A&#x003b2;(25-35)-induced neuroinflammation</article-title>. <source>Behav. Brain Res.</source>
<volume>365</volume>, <fpage>48</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2019.03.001</pub-id>
<pub-id pub-id-type="pmid">30831140</pub-id>
</mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Cai</surname><given-names>J.</given-names></name><name><surname>Qiu</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>H.</given-names></name><name><surname>Lai</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Targeted homing of CCR2-overexpressing mesenchymal stromal cells to ischemic brain enhances post-stroke recovery partially through PRDX4-mediated blood-brain barrier preservation</article-title>. <source>Theranostics</source>
<volume>8</volume> (<issue>21</issue>), <fpage>5929</fpage>&#x02013;<lpage>5944</lpage>. <pub-id pub-id-type="doi">10.7150/thno.28029</pub-id>
<pub-id pub-id-type="pmid">30613272</pub-id>
</mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hussen</surname><given-names>B. M.</given-names></name><name><surname>Taheri</surname><given-names>M.</given-names></name><name><surname>Yashooa</surname><given-names>R. K.</given-names></name><name><surname>Abdullah</surname><given-names>G. H.</given-names></name><name><surname>Abdullah</surname><given-names>S. R.</given-names></name><name><surname>Kheder</surname><given-names>R. K.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Revolutionizing medicine: recent developments and future prospects in stem-cell therapy</article-title>. <volume>110</volume>(<issue>12</issue>), <fpage>8002</fpage>&#x02013;<lpage>8024</lpage>. <pub-id pub-id-type="doi">10.1097/js9.0000000000002109</pub-id>
</mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ishaque</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>I.</given-names></name><name><surname>Salim</surname><given-names>A.</given-names></name><name><surname>Qazi</surname><given-names>R. E.</given-names></name><name><surname>Malick</surname><given-names>T. S.</given-names></name><name><surname>Adli</surname><given-names>D. S. H.</given-names></name></person-group> (<year>2022</year>). <article-title>Effect of &#x003b1;-pinene and thymoquinone on the differentiation of bone marrow mesenchymal stem cells into neuroprogenitor cells</article-title>. <source>Bioimpacts</source>
<volume>12</volume> (<issue>2</issue>), <fpage>147</fpage>&#x02013;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.34172/bi.2021.23634</pub-id>
<pub-id pub-id-type="pmid">35411294</pub-id>
</mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jahan</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>D.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Srivastava</surname><given-names>A.</given-names></name><name><surname>Pandey</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2018a</year>). <article-title>Resveratrol prevents the cellular damages induced by monocrotophos via PI3K signaling pathway in human cord blood mesenchymal stem cells</article-title>. <source>Mol. Neurobiol.</source>
<volume>55</volume> (<issue>11</issue>), <fpage>8278</fpage>&#x02013;<lpage>8292</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-018-0986-z</pub-id>
<pub-id pub-id-type="pmid">29526017</pub-id>
</mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jahan</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Srivastava</surname><given-names>A.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Kumar</surname><given-names>D.</given-names></name><name><surname>Pandey</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2018b</year>). <article-title>PKA-GSK3&#x003b2; and &#x003b2;-catenin signaling play a critical role in trans-resveratrol mediated neuronal differentiation in human cord blood stem cells</article-title>. <source>Mol. Neurobiol.</source>
<volume>55</volume> (<issue>4</issue>), <fpage>2828</fpage>&#x02013;<lpage>2839</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-017-0539-x</pub-id>
<pub-id pub-id-type="pmid">28455695</pub-id>
</mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Ni</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>L.</given-names></name><name><surname>Xiang</surname><given-names>Z.</given-names></name><name><surname>Zeng</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Resveratrol may reduce the degree of periodontitis by regulating ERK pathway in gingival-derived MSCs</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>24</volume> (<issue>14</issue>), <fpage>11294</fpage>. <pub-id pub-id-type="doi">10.3390/ijms241411294</pub-id>
<pub-id pub-id-type="pmid">37511053</pub-id>
</mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiao</surname><given-names>F.</given-names></name><name><surname>Tang</surname><given-names>W.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Icariin promotes the migration of BMSCs <italic>in vitro</italic> and <italic>in vivo</italic> via the MAPK signaling pathway</article-title>. <source>Stem Cells Int.</source>
<volume>2018</volume>, <fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1155/2018/2562105</pub-id>
</mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Joe</surname><given-names>I. S.</given-names></name><name><surname>Jeong</surname><given-names>S. G.</given-names></name><name><surname>Cho</surname><given-names>G. W.</given-names></name></person-group> (<year>2015</year>). <article-title>Resveratrol-induced SIRT1 activation promotes neuronal differentiation of human bone marrow mesenchymal stem cells</article-title>. <source>Neurosci. Lett.</source>
<volume>584</volume>, <fpage>97</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2014.10.024</pub-id>
<pub-id pub-id-type="pmid">25459285</pub-id>
</mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaiser</surname><given-names>E. E.</given-names></name><name><surname>Waters</surname><given-names>E. S.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Fagan</surname><given-names>M. M.</given-names></name><name><surname>Scheulin</surname><given-names>K. M.</given-names></name><name><surname>Sneed</surname><given-names>S. E.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Tanshinone IIA-loaded nanoparticle and neural stem cell therapy enhances recovery in a pig ischemic stroke model</article-title>. <source>Stem Cells Transl. Med.</source>
<volume>11</volume> (<issue>10</issue>), <fpage>1061</fpage>&#x02013;<lpage>1071</lpage>. <pub-id pub-id-type="doi">10.1093/stcltm/szac062</pub-id>
<pub-id pub-id-type="pmid">36124817</pub-id>
</mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khattar</surname><given-names>S.</given-names></name><name><surname>Khan</surname><given-names>S. A.</given-names></name><name><surname>Zaidi</surname><given-names>S. A. A.</given-names></name><name><surname>Darvishikolour</surname><given-names>M.</given-names></name><name><surname>Farooq</surname><given-names>U.</given-names></name><name><surname>Naseef</surname><given-names>P. P.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Resveratrol from dietary supplement to a drug candidate: an assessment of potential</article-title>. <source>Pharm. (Basel).</source>
<volume>15</volume> (<issue>8</issue>), <fpage>957</fpage>. <pub-id pub-id-type="doi">10.3390/ph15080957</pub-id>
</mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>D. H.</given-names></name><name><surname>Jo</surname><given-names>S.</given-names></name><name><surname>Cho</surname><given-names>M. J.</given-names></name><name><surname>Cho</surname><given-names>Y. R.</given-names></name><name><surname>Lee</surname><given-names>Y. J.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Immunomodulatory functional foods and their molecular mechanisms</article-title>. <source>Exp. Mol. Med.</source>
<volume>54</volume> (<issue>1</issue>), <fpage>1</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1038/s12276-022-00724-0</pub-id>
<pub-id pub-id-type="pmid">35079119</pub-id>
</mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lakshminarayanan</surname><given-names>A.</given-names></name><name><surname>Kannan</surname><given-names>S.</given-names></name><name><surname>Kuppusamy</surname><given-names>M. K.</given-names></name><name><surname>Sankaranarayanan</surname><given-names>K.</given-names></name><name><surname>Godla</surname><given-names>U.</given-names></name><name><surname>Punnoose</surname><given-names>A. M.</given-names></name></person-group> (<year>2025</year>). <article-title>The effect of curcumin, catechin and resveratrol on viability, proliferation and cytotoxicity of human umbilical cord wharton&#x02019;s jelly derived mesenchymal stem cells</article-title>. <source>Tissue Cell</source>
<volume>93</volume>, <fpage>102742</fpage>. <pub-id pub-id-type="doi">10.1016/j.tice.2025.102742</pub-id>
<pub-id pub-id-type="pmid">39874919</pub-id>
</mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lan</surname><given-names>T.</given-names></name><name><surname>Luo</surname><given-names>M.</given-names></name><name><surname>Wei</surname><given-names>X.</given-names></name></person-group> (<year>2021</year>). <article-title>Mesenchymal stem/stromal cells in cancer therapy</article-title>. <source>J. Hematol. Oncol.</source>
<volume>14</volume> (<issue>1</issue>), <fpage>195</fpage>. <pub-id pub-id-type="doi">10.1186/s13045-021-01208-w</pub-id>
<pub-id pub-id-type="pmid">34789315</pub-id>
</mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Han</surname><given-names>R.</given-names></name><name><surname>Wu</surname><given-names>M.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Therapeutic potential of Chinese medicine for endogenous neurogenesis: a promising candidate for stroke treatment</article-title>. <source>Pharm. (Basel)</source>
<volume>16</volume> (<issue>5</issue>), <fpage>706</fpage>. <pub-id pub-id-type="doi">10.3390/ph16050706</pub-id>
</mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Hou</surname><given-names>Q.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Zhong</surname><given-names>L.</given-names></name><name><surname>Fu</surname><given-names>X.</given-names></name></person-group> (<year>2022</year>). <article-title>Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: current status and future prospects</article-title>. <source>Stem Cell Res. Ther.</source>
<volume>13</volume> (<issue>1</issue>), <fpage>146</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-022-02822-2</pub-id>
<pub-id pub-id-type="pmid">35379361</pub-id>
</mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Mi</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Synovial membrane mesenchymal stem cells: past life, current situation, and application in bone and joint diseases</article-title>. <source>Stem Cell Res. Ther.</source>
<volume>11</volume> (<issue>1</issue>), <fpage>381</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-020-01885-3</pub-id>
<pub-id pub-id-type="pmid">32894205</pub-id>
</mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Xiang</surname><given-names>Z.</given-names></name><name><surname>Yu</surname><given-names>W.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Jiang</surname><given-names>Q.</given-names></name><name><surname>Abumansour</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Natural compounds and mesenchymal stem cells: implications for inflammatory-impaired tissue regeneration</article-title>. <source>Stem Cell Res. Ther.</source>
<volume>15</volume> (<issue>1</issue>), <fpage>34</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-024-03641-3</pub-id>
<pub-id pub-id-type="pmid">38321524</pub-id>
</mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Ye</surname><given-names>Y. C.</given-names></name><name><surname>Shi</surname><given-names>Z. X.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Tanshinone IIA and Astragaloside IV promote the angiogenesis of mesenchymal stem cell-derived endothelial cell-like cells via upregulation of Cx37, Cx40 and Cx43</article-title>. <source>Exp. Ther. Med.</source>
<volume>15</volume> (<issue>2</issue>), <fpage>1847</fpage>&#x02013;<lpage>1854</lpage>. <pub-id pub-id-type="doi">10.3892/etm.2017.5636</pub-id>
<pub-id pub-id-type="pmid">29434774</pub-id>
</mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>B.</given-names></name><name><surname>Liang</surname><given-names>D.</given-names></name><name><surname>Quan</surname><given-names>X.</given-names></name><name><surname>Gu</surname><given-names>R.</given-names></name><name><surname>Meng</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Pharmacological effects of astragaloside IV: a review</article-title>. <source>Molecules</source>
<volume>28</volume> (<issue>16</issue>), <fpage>6118</fpage>. <pub-id pub-id-type="doi">10.3390/molecules28166118</pub-id>
<pub-id pub-id-type="pmid">37630371</pub-id>
</mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lim</surname><given-names>R. Z. L.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Yong</surname><given-names>E. L.</given-names></name><name><surname>Chew</surname><given-names>N.</given-names></name></person-group> (<year>2018</year>). <article-title>STAT-3 regulation of CXCR4 is necessary for the prenylflavonoid Icaritin to enhance mesenchymal stem cell proliferation, migration and osteogenic differentiation</article-title>. <source>Biochim. Biophys. Acta Gen. Subj.</source>
<volume>1862</volume> (<issue>7</issue>), <fpage>1680</fpage>&#x02013;<lpage>1692</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2018.04.016</pub-id>
<pub-id pub-id-type="pmid">29679717</pub-id>
</mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name></person-group> (<year>2022</year>). <article-title>Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential</article-title>. <source>Mol. Cancer</source>
<volume>21</volume> (<issue>1</issue>), <fpage>179</fpage>. <pub-id pub-id-type="doi">10.1186/s12943-022-01650-5</pub-id>
<pub-id pub-id-type="pmid">36100944</pub-id>
</mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Xiong</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Gao</surname><given-names>H.</given-names></name><name><surname>Yin</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Icariin improves osteoporosis, inhibits the expression of PPAR&#x003b3;, C/EBP&#x003b1;, FABP4 mRNA, N1ICD and jagged1 proteins, and increases Notch2 mRNA in ovariectomized rats</article-title>. <source>Exp. Ther. Med.</source>
<volume>13</volume> (<issue>4</issue>), <fpage>1360</fpage>&#x02013;<lpage>1368</lpage>. <pub-id pub-id-type="doi">10.3892/etm.2017.4128</pub-id>
<pub-id pub-id-type="pmid">28413478</pub-id>
</mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>P.</given-names></name><name><surname>Song</surname><given-names>P.</given-names></name><name><surname>Xiong</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Peng</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Pretreatment of adipose derived stem cells with curcumin facilitates myocardial recovery via antiapoptosis and angiogenesis</article-title>. <source>Stem Cells Int.</source>
<volume>2015</volume>, <fpage>1</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1155/2015/638153</pub-id>
</mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Niu</surname><given-names>Y.</given-names></name><name><surname>Xie</surname><given-names>W.</given-names></name><name><surname>Wei</surname><given-names>D.</given-names></name><name><surname>Du</surname><given-names>Q.</given-names></name></person-group> (<year>2019</year>). <article-title>Tanshinone IIA promotes osteogenic differentiation of human periodontal ligament stem cells via ERK1/2-dependent Runx2 induction</article-title>. <source>Am. J. Transl. Res.</source>
<volume>11</volume> (<issue>1</issue>), <fpage>340</fpage>&#x02013;<lpage>350</lpage>.<pub-id pub-id-type="pmid">30787991</pub-id>
</mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y. L.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Wen</surname><given-names>J. T.</given-names></name><name><surname>Teng</surname><given-names>S. J.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Protective effects of Gingko biloba extract 761 on myocardial infarction via improving the viability of implanted mesenchymal stem cells in the rat heart</article-title>. <source>Mol. Med. Rep.</source>
<volume>9</volume> (<issue>4</issue>), <fpage>1112</fpage>&#x02013;<lpage>1120</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2014.1959</pub-id>
<pub-id pub-id-type="pmid">24549494</pub-id>
</mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Cheng</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name></person-group> (<year>2025</year>). <article-title>From bench to bedside: future prospects in stem cell therapy for diabetes</article-title>. <source>J. Transl. Med.</source>
<volume>23</volume> (<issue>1</issue>), <fpage>72</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-024-06019-4</pub-id>
<pub-id pub-id-type="pmid">39815257</pub-id>
</mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Shu</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Xia</surname><given-names>W.</given-names></name><name><surname>Tang</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Human placental mesenchymal stem cells ameliorate chemotherapy-induced damage in the testis by reducing apoptosis/oxidative stress and promoting autophagy</article-title>. <source>Stem Cell Res. Ther.</source>
<volume>12</volume> (<issue>1</issue>), <fpage>199</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-021-02275-z</pub-id>
<pub-id pub-id-type="pmid">33743823</pub-id>
</mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>A.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Dai</surname><given-names>X.</given-names></name><name><surname>Liang</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Ginsenosides in central nervous system diseases: pharmacological actions, mechanisms, and therapeutics</article-title>. <source>Phytother. Res.</source>
<volume>36</volume> (<issue>4</issue>), <fpage>1523</fpage>&#x02013;<lpage>1544</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.7395</pub-id>
<pub-id pub-id-type="pmid">35084783</pub-id>
</mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lunn</surname><given-names>J. S.</given-names></name><name><surname>Sakowski</surname><given-names>S. A.</given-names></name><name><surname>Hur</surname><given-names>J.</given-names></name><name><surname>Feldman</surname><given-names>E. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Stem cell technology for neurodegenerative diseases</article-title>. <source>Ann. Neurol.</source>
<volume>70</volume> (<issue>3</issue>), <fpage>353</fpage>&#x02013;<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22487</pub-id>
<pub-id pub-id-type="pmid">21905078</pub-id>
</mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lv</surname><given-names>Y. J.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Sui</surname><given-names>B. D.</given-names></name><name><surname>Hu</surname><given-names>C. H.</given-names></name><name><surname>Zhao</surname><given-names>P.</given-names></name><name><surname>Liao</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Resveratrol counteracts bone loss via mitofilin-mediated osteogenic improvement of mesenchymal stem cells in senescence-accelerated mice</article-title>. <source>Theranostics</source>
<volume>8</volume> (<issue>9</issue>), <fpage>2387</fpage>&#x02013;<lpage>2406</lpage>. <pub-id pub-id-type="doi">10.7150/thno.23620</pub-id>
<pub-id pub-id-type="pmid">29721087</pub-id>
</mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maeda</surname><given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>Recruitment of mesenchymal stem cells to damaged sites by plant-derived components</article-title>. <source>Front. Cell Dev. Biol.</source>
<volume>8</volume>, <fpage>437</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2020.00437</pub-id>
<pub-id pub-id-type="pmid">32582713</pub-id>
</mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mahmoudi</surname><given-names>F.</given-names></name><name><surname>Jalayeri</surname><given-names>M. H. T.</given-names></name><name><surname>Montaseri</surname><given-names>A.</given-names></name><name><surname>MohamedKhosroshahi</surname><given-names>L.</given-names></name><name><surname>Baradaran</surname><given-names>B.</given-names></name></person-group> (<year>2024</year>). <article-title>Microbial natural compounds and secondary metabolites as Immunomodulators: a review</article-title>. <source>Int. J. Biol. Macromol.</source>
<volume>278</volume> (<issue>Pt 3</issue>), <fpage>134778</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2024.134778</pub-id>
<pub-id pub-id-type="pmid">39153680</pub-id>
</mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Masuda</surname><given-names>K.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name><name><surname>Kato</surname><given-names>H.</given-names></name><name><surname>Sato</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Dental pulp-derived mesenchymal stem cells for modeling genetic disorders</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>22</volume> (<issue>5</issue>), <fpage>2269</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22052269</pub-id>
<pub-id pub-id-type="pmid">33668763</pub-id>
</mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsuzaka</surname><given-names>Y.</given-names></name><name><surname>Yashiro</surname><given-names>R.</given-names></name></person-group> (<year>2024</year>). <article-title>Current strategies and therapeutic applications of mesenchymal stem cell-based drug delivery</article-title>. <source>Pharm. (Basel)</source>
<volume>17</volume> (<issue>6</issue>), <fpage>707</fpage>. <pub-id pub-id-type="doi">10.3390/ph17060707</pub-id>
</mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mekhemar</surname><given-names>M.</given-names></name><name><surname>Hassan</surname><given-names>Y.</given-names></name><name><surname>D&#x000f6;rfer</surname><given-names>C.</given-names></name></person-group> (<year>2020</year>). <article-title>Nigella sativa and thymoquinone: a natural blessing for periodontal therapy</article-title>. <source>Antioxidants (Basel)</source>
<volume>9</volume> (<issue>12</issue>), <fpage>1260</fpage>. <pub-id pub-id-type="doi">10.3390/antiox9121260</pub-id>
<pub-id pub-id-type="pmid">33322636</pub-id>
</mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mekhemar</surname><given-names>M.</given-names></name><name><surname>T&#x000f6;lle</surname><given-names>J.</given-names></name><name><surname>Hassan</surname><given-names>Y.</given-names></name><name><surname>D&#x000f6;rfer</surname><given-names>C.</given-names></name><name><surname>El-Sayed</surname><given-names>K. F.</given-names></name></person-group> (<year>2022</year>). <article-title>Thymoquinone-mediated modulation of toll-like receptors and pluripotency factors in gingival mesenchymal stem/progenitor cells</article-title>. <source>Cells</source>
<volume>11</volume> (<issue>9</issue>), <fpage>1452</fpage>. <pub-id pub-id-type="doi">10.3390/cells11091452</pub-id>
<pub-id pub-id-type="pmid">35563755</pub-id>
</mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moon</surname><given-names>D.-O.</given-names></name></person-group> (<year>2024</year>). <article-title>Curcumin in cancer and inflammation: an in-depth exploration of molecular interactions, therapeutic potentials, and the role in disease management</article-title>. <source>Management</source>
<volume>25</volume> (<issue>5</issue>), <fpage>2911</fpage>. <pub-id pub-id-type="doi">10.3390/ijms25052911</pub-id>
</mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mousavi</surname><given-names>S. N.</given-names></name><name><surname>Hosseinikia</surname><given-names>M.</given-names></name><name><surname>Yousefi Rad</surname><given-names>E.</given-names></name><name><surname>Saboori</surname><given-names>S. J. P. R.</given-names></name></person-group> (<year>2022</year>). <article-title>Beneficial effects of Ginkgo biloba leaf extract on inflammatory markers: a systematic review and meta&#x02010;analysis of the clinical trials</article-title>. <volume>36</volume>(<issue>9</issue>), <fpage>3459</fpage>&#x02013;<lpage>3469</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.7544</pub-id>
</mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Najar</surname><given-names>M.</given-names></name><name><surname>Bouhtit</surname><given-names>F.</given-names></name><name><surname>Rahmani</surname><given-names>S.</given-names></name><name><surname>Bouali</surname><given-names>A.</given-names></name><name><surname>Melki</surname><given-names>R.</given-names></name><name><surname>Najimi</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>The immunogenic profile and immunomodulatory function of mesenchymal stromal/stem cells in the presence of Ptychotis verticillata</article-title>. <source>Heliyon</source>
<volume>10</volume> (<issue>3</issue>), <fpage>e24822</fpage>. <pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e24822</pub-id>
<pub-id pub-id-type="pmid">38317994</pub-id>
</mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ng</surname><given-names>T. W.</given-names></name><name><surname>Tan</surname><given-names>P. P. S.</given-names></name><name><surname>Lim</surname><given-names>H. M.</given-names></name><name><surname>Kumar</surname><given-names>D. N.</given-names></name><name><surname>Zain</surname><given-names>S. M.</given-names></name><name><surname>Low</surname><given-names>T. Y.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Potential medicinal herb for cardiovascular health: a comprehensive review on salviae miltiorrhizae</article-title>. <volume>51</volume>(<issue>1</issue>), <fpage>1</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.55230/mabjournal.v51i1.2056</pub-id>
</mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nie</surname><given-names>L.</given-names></name><name><surname>Yao</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Pan</surname><given-names>C.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Directional induction of neural stem cells, a new therapy for neurodegenerative diseases and ischemic stroke</article-title>. <source>Cell Death Discov.</source>
<volume>9</volume> (<issue>1</issue>), <fpage>215</fpage>. <pub-id pub-id-type="doi">10.1038/s41420-023-01532-9</pub-id>
<pub-id pub-id-type="pmid">37393356</pub-id>
</mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Niu</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Xue</surname><given-names>C.</given-names></name><name><surname>Zhu</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Astragaloside IV promotes antiphotoaging by enhancing the proliferation and paracrine activity of adipose-derived stem cells</article-title>. <source>Stem Cells Dev.</source>
<volume>29</volume> (<issue>19</issue>), <fpage>1285</fpage>&#x02013;<lpage>1293</lpage>. <pub-id pub-id-type="doi">10.1089/scd.2020.0092</pub-id>
<pub-id pub-id-type="pmid">32703122</pub-id>
</mixed-citation></ref><ref id="B170"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Okay</surname><given-names>E. T.</given-names></name><name><surname>Simsek</surname><given-names>C.</given-names></name><name><surname>Gunes</surname><given-names>A.</given-names></name><name><surname>Duruksu</surname><given-names>G.</given-names></name><name><surname>Gurbuz</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Cross effects of resveratrol and mesenchymal stem cells on liver regeneration and homing in partially hepatectomized rats[J]</article-title>. <source>Stem Cell Rev. Rep.</source>
<volume>11</volume> (<issue>2</issue>), <fpage>322</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1007/s12015-014-9572-6</pub-id>
<pub-id pub-id-type="pmid">25416627</pub-id>
</mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pacyga</surname><given-names>K.</given-names></name><name><surname>Pacyga</surname><given-names>P.</given-names></name><name><surname>Topola</surname><given-names>E.</given-names></name><name><surname>Viscardi</surname><given-names>S.</given-names></name><name><surname>Duda-Madej</surname><given-names>A.</given-names></name></person-group> (<year>2024</year>). <article-title>Bioactive compounds from plant origin as natural antimicrobial agents for the treatment of wound infections</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>25</volume> (<issue>4</issue>), <fpage>2100</fpage>. <pub-id pub-id-type="doi">10.3390/ijms25042100</pub-id>
<pub-id pub-id-type="pmid">38396777</pub-id>
</mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pang</surname><given-names>X.</given-names></name><name><surname>Zhong</surname><given-names>Z.</given-names></name><name><surname>Jiang</surname><given-names>F.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Nie</surname><given-names>H.</given-names></name></person-group> (<year>2022</year>). <article-title>Juglans regia L. extract promotes osteogenesis of human bone marrow mesenchymal stem cells through BMP2/Smad/Runx2 and Wnt/&#x003b2;-catenin pathways</article-title>. <source>J. Orthop. Surg. Res.</source>
<volume>17</volume> (<issue>1</issue>), <fpage>88</fpage>. <pub-id pub-id-type="doi">10.1186/s13018-022-02949-1</pub-id>
<pub-id pub-id-type="pmid">35164786</pub-id>
</mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pharoun</surname><given-names>J.</given-names></name><name><surname>Berro</surname><given-names>J.</given-names></name><name><surname>Sobh</surname><given-names>J.</given-names></name><name><surname>Abou-Younes</surname><given-names>M. M.</given-names></name><name><surname>Nasr</surname><given-names>L.</given-names></name><name><surname>Majed</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Mesenchymal stem cells biological and biotechnological advances: implications for clinical applications</article-title>. <source>Eur. J. Pharmacol.</source>
<volume>977</volume>, <fpage>176719</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2024.176719</pub-id>
<pub-id pub-id-type="pmid">38849038</pub-id>
</mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pirmoradi</surname><given-names>S.</given-names></name><name><surname>Fathi</surname><given-names>E.</given-names></name><name><surname>Farahzadi</surname><given-names>R.</given-names></name><name><surname>Pilehvar-Soltanahmadi</surname><given-names>Y.</given-names></name><name><surname>Zarghami</surname><given-names>N.</given-names></name></person-group> (<year>2018</year>). <article-title>Curcumin affects adipose tissue-derived mesenchymal stem cell aging through TERT gene expression</article-title>. <source>Drug Res. (Stuttg)</source>
<volume>68</volume> (<issue>4</issue>), <fpage>213</fpage>&#x02013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1055/s-0043-119635</pub-id>
<pub-id pub-id-type="pmid">29017189</pub-id>
</mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Poon</surname><given-names>E.N.-Y.</given-names></name><name><surname>Luo</surname><given-names>X.-l.</given-names></name><name><surname>Webb</surname><given-names>S. E.</given-names></name><name><surname>Yan</surname><given-names>B.</given-names></name><name><surname>Zhao</surname><given-names>R.</given-names></name><name><surname>Wu</surname><given-names>S. C. M.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>The cell surface marker CD36 selectively identifies matured, mitochondria-rich hPSC-cardiomyocytes</article-title>. <source>Cell Res.</source>
<volume>30</volume> (<issue>7</issue>), <fpage>626</fpage>&#x02013;<lpage>629</lpage>. <pub-id pub-id-type="doi">10.1038/s41422-020-0292-y</pub-id>
<pub-id pub-id-type="pmid">32157205</pub-id>
</mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Preda</surname><given-names>M. B.</given-names></name><name><surname>Neculachi</surname><given-names>C. A.</given-names></name><name><surname>Fenyo</surname><given-names>I. M.</given-names></name><name><surname>Vacaru</surname><given-names>A. M.</given-names></name><name><surname>Publik</surname><given-names>M. A.</given-names></name><name><surname>Simionescu</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Short lifespan of syngeneic transplanted MSC is a consequence of <italic>in vivo</italic> apoptosis and immune cell recruitment in mice</article-title>. <source>Cell Death Dis.</source>
<volume>12</volume> (<issue>6</issue>), <fpage>566</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-021-03839-w</pub-id>
<pub-id pub-id-type="pmid">34075029</pub-id>
</mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pu</surname><given-names>X.</given-names></name><name><surname>Chai</surname><given-names>Y.</given-names></name><name><surname>Guan</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Jiang</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Astragalus improve aging bone marrow mesenchymal stem cells (BMSCs) vitality and osteogenesis through VD-FGF23-Klotho axis</article-title>. <source>Int. J. Clin. Exp. Pathol.</source>
<volume>13</volume> (<issue>4</issue>), <fpage>721</fpage>&#x02013;<lpage>729</lpage>. <pub-id pub-id-type="doi">10.62347/IJCEP.2020.13.4.721</pub-id>
<pub-id pub-id-type="pmid">32355520</pub-id>
</mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qin</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Block</surname><given-names>M. L.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Breese</surname><given-names>G. R.</given-names></name><name><surname>Hong</surname><given-names>J. S.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration</article-title>. <source>Glia</source>
<volume>55</volume> (<issue>5</issue>), <fpage>453</fpage>&#x02013;<lpage>462</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20467</pub-id>
<pub-id pub-id-type="pmid">17203472</pub-id>
</mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rahmani-Moghadam</surname><given-names>E.</given-names></name><name><surname>Talaei-Khozani</surname><given-names>T.</given-names></name><name><surname>Zarrin</surname><given-names>V.</given-names></name><name><surname>Vojdani</surname><given-names>Z.</given-names></name></person-group> (<year>2021</year>). <article-title>Thymoquinone loading into hydroxyapatite/alginate scaffolds accelerated the osteogenic differentiation of the mesenchymal stem cells</article-title>. <source>Biomed. Eng. Online</source>
<volume>20</volume> (<issue>1</issue>), <fpage>76</fpage>. <pub-id pub-id-type="doi">10.1186/s12938-021-00916-1</pub-id>
<pub-id pub-id-type="pmid">34348708</pub-id>
</mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rahmani-Moghadam</surname><given-names>E.</given-names></name><name><surname>Zarrin</surname><given-names>V.</given-names></name><name><surname>Mahmoodzadeh</surname><given-names>A.</given-names></name><name><surname>Owrang</surname><given-names>M.</given-names></name><name><surname>Talaei-Khozani</surname><given-names>T.</given-names></name></person-group> (<year>2022</year>). <article-title>Comparison of the characteristics of breast milk-derived stem cells with the stem cells derived from the other sources: a comparative review</article-title>. <source>Curr. Stem Cell Res. Ther.</source>
<volume>17</volume> (<issue>1</issue>), <fpage>71</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.2174/1574888x16666210622125309</pub-id>
<pub-id pub-id-type="pmid">34161214</pub-id>
</mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rangasamy</surname><given-names>T.</given-names></name><name><surname>Ghimire</surname><given-names>L.</given-names></name><name><surname>Jin</surname><given-names>L.</given-names></name><name><surname>Le</surname><given-names>J.</given-names></name><name><surname>Periasamy</surname><given-names>S.</given-names></name><name><surname>Paudel</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Host defense against <italic>Klebsiella pneumoniae</italic> pneumonia is augmented by lung-derived mesenchymal stem cells</article-title>. <source>J. Immunol.</source>
<volume>207</volume> (<issue>4</issue>), <fpage>1112</fpage>&#x02013;<lpage>1127</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.2000688</pub-id>
<pub-id pub-id-type="pmid">34341173</pub-id>
</mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rendra</surname><given-names>E.</given-names></name><name><surname>Crigna</surname><given-names>A. T.</given-names></name><name><surname>Daniele</surname><given-names>C.</given-names></name><name><surname>Sticht</surname><given-names>C.</given-names></name><name><surname>Cueppers</surname><given-names>M.</given-names></name><name><surname>Kluth</surname><given-names>M. A.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Clinical-grade human skin-derived ABCB5+ mesenchymal stromal cells exert anti-apoptotic and anti-inflammatory effects <italic>in vitro</italic> and modulate mRNA expression in a cisplatin-induced kidney injury murine model</article-title>. <source>Front. Immunol.</source>
<volume>14</volume>, <fpage>1228928</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2023.1228928</pub-id>
<pub-id pub-id-type="pmid">38274791</pub-id>
</mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez-Eguren</surname><given-names>A.</given-names></name><name><surname>G&#x000f3;mez-&#x000c1;lvarez</surname><given-names>M.</given-names></name><name><surname>Franc&#x000e9;s-Herrero</surname><given-names>E.</given-names></name><name><surname>Romeu</surname><given-names>M.</given-names></name><name><surname>Ferrero</surname><given-names>H.</given-names></name><name><surname>Seli</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Human umbilical cord-based therapeutics: stem cells and blood derivatives for female reproductive</article-title>. <source>medicine</source>
<volume>23</volume> (<issue>24</issue>), <fpage>15942</fpage>
<pub-id pub-id-type="doi">10.3390/ijms232415942</pub-id>
</mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Samsonraj</surname><given-names>R. M.</given-names></name><name><surname>Raghunath</surname><given-names>M.</given-names></name><name><surname>Nurcombe</surname><given-names>V.</given-names></name><name><surname>Hui</surname><given-names>J. H.</given-names></name><name><surname>van Wijnen</surname><given-names>A. J.</given-names></name><name><surname>Cool</surname><given-names>S. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine</article-title>. <source>Stem Cells Transl. Med.</source>
<volume>6</volume> (<issue>12</issue>), <fpage>2173</fpage>&#x02013;<lpage>2185</lpage>. <pub-id pub-id-type="doi">10.1002/sctm.17-0129</pub-id>
<pub-id pub-id-type="pmid">29076267</pub-id>
</mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Santra</surname><given-names>M.</given-names></name><name><surname>Geary</surname><given-names>M. L.</given-names></name><name><surname>Rubin</surname><given-names>E.</given-names></name><name><surname>Hsu</surname><given-names>M. Y. S.</given-names></name><name><surname>Funderburgh</surname><given-names>M. L.</given-names></name><name><surname>Chandran</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Good manufacturing practice production of human corneal limbus-derived stromal stem cells and <italic>in vitro</italic> quality screening for therapeutic inhibition of corneal scarring</article-title>. <source>Stem Cell Res. Ther.</source>
<volume>15</volume> (<issue>1</issue>), <fpage>11</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-023-03626-8</pub-id>
<pub-id pub-id-type="pmid">38185673</pub-id>
</mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seo</surname><given-names>Y.</given-names></name><name><surname>Shin</surname><given-names>T. H.</given-names></name><name><surname>Kim</surname><given-names>H. S.</given-names></name></person-group> (<year>2019</year>). <article-title>Current strategies to enhance adipose stem cell function: an update</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>20</volume> (<issue>15</issue>), <fpage>3827</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20153827</pub-id>
<pub-id pub-id-type="pmid">31387282</pub-id>
</mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Serteyn</surname><given-names>D.</given-names></name><name><surname>Storms</surname><given-names>N.</given-names></name><name><surname>Mouithys-Mickalad</surname><given-names>A.</given-names></name><name><surname>Sandersen</surname><given-names>C.</given-names></name><name><surname>Niesten</surname><given-names>A.</given-names></name><name><surname>Duysens</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Revealing the therapeutic potential of muscle-derived mesenchymal stem/stromal cells: an <italic>in vitro</italic> model for equine laminitis based on activated neutrophils, anoxia-reoxygenation, and myeloperoxidase</article-title>. <source>Anim. (Basel)</source>
<volume>14</volume> (<issue>18</issue>), <fpage>2681</fpage>. <pub-id pub-id-type="doi">10.3390/ani14182681</pub-id>
</mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seyedi</surname><given-names>Z.</given-names></name><name><surname>Amiri</surname><given-names>M. S.</given-names></name><name><surname>Mohammadzadeh</surname><given-names>V.</given-names></name><name><surname>Hashemzadeh</surname><given-names>A.</given-names></name><name><surname>Haddad-Mashadrizeh</surname><given-names>A.</given-names></name><name><surname>Mashreghi</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Icariin: a promising natural product in biomedicine and tissue engineering</article-title>. <source>J. Funct. Biomater.</source>
<volume>14</volume> (<issue>1</issue>), <fpage>44</fpage>. <pub-id pub-id-type="doi">10.3390/jfb14010044</pub-id>
<pub-id pub-id-type="pmid">36662090</pub-id>
</mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shan</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Tao</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wei</surname><given-names>N.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges</article-title>. <source>Signal Transduct. Target Ther.</source>
<volume>9</volume> (<issue>1</issue>), <fpage>242</fpage>. <pub-id pub-id-type="doi">10.1038/s41392-024-01936-8</pub-id>
<pub-id pub-id-type="pmid">39271680</pub-id>
</mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sharifi</surname><given-names>S.</given-names></name><name><surname>Moghaddam</surname><given-names>F. A.</given-names></name><name><surname>Abedi</surname><given-names>A.</given-names></name><name><surname>Maleki Dizaj</surname><given-names>S.</given-names></name><name><surname>Ahmadian</surname><given-names>S.</given-names></name><name><surname>Abdolahinia</surname><given-names>E. D.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Phytochemicals impact on osteogenic differentiation of mesenchymal stem cells</article-title>. <source>Biofactors</source>
<volume>46</volume> (<issue>6</issue>), <fpage>874</fpage>&#x02013;<lpage>893</lpage>. <pub-id pub-id-type="doi">10.1002/biof.1682</pub-id>
<pub-id pub-id-type="pmid">33037744</pub-id>
</mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sheng</surname><given-names>H.</given-names></name><name><surname>Rui</surname><given-names>X. F.</given-names></name><name><surname>Sheng</surname><given-names>C. J.</given-names></name><name><surname>Li</surname><given-names>W. J.</given-names></name><name><surname>Cheng</surname><given-names>X. Y.</given-names></name><name><surname>Jhummon</surname><given-names>N. P.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>A novel semisynthetic molecule icaritin stimulates osteogenic differentiation and inhibits adipogenesis of mesenchymal stem cells</article-title>. <source>Int. J. Med. Sci.</source>
<volume>10</volume> (<issue>6</issue>), <fpage>782</fpage>&#x02013;<lpage>789</lpage>. <pub-id pub-id-type="doi">10.7150/ijms.6084</pub-id>
<pub-id pub-id-type="pmid">23630444</pub-id>
</mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Si</surname><given-names>Y. C.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Xie</surname><given-names>C. E.</given-names></name><name><surname>Niu</surname><given-names>X.</given-names></name><name><surname>Xia</surname><given-names>X. H.</given-names></name><name><surname>Yu</surname><given-names>C. Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Chinese herbs and their active ingredients for activating xue (blood) promote the proliferation and differentiation of neural stem cells and mesenchymal stem cells</article-title>. <source>Chin. Med.</source>
<volume>9</volume> (<issue>1</issue>), <fpage>13</fpage>. <pub-id pub-id-type="doi">10.1186/1749-8546-9-13</pub-id>
<pub-id pub-id-type="pmid">24716802</pub-id>
</mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Song</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Fan</surname><given-names>W.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Menstrual blood-derived endometrial stem cells ameliorate ovarian senescence by relieving oxidative stress-induced inflammation</article-title>. <source>Reprod. Sci</source>. <pub-id pub-id-type="doi">10.1007/s43032-024-01739-w</pub-id>
</mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Song</surname><given-names>L. H.</given-names></name><name><surname>Pan</surname><given-names>W.</given-names></name><name><surname>Yu</surname><given-names>Y. H.</given-names></name><name><surname>Quarles</surname><given-names>L. D.</given-names></name><name><surname>Zhou</surname><given-names>H. H.</given-names></name><name><surname>Xiao</surname><given-names>Z. S.</given-names></name></person-group> (<year>2006</year>). <article-title>Resveratrol prevents CsA inhibition of proliferation and osteoblastic differentiation of mouse bone marrow-derived mesenchymal stem cells through an ER/NO/cGMP pathway</article-title>. <source>Toxicol In Vitro</source>
<volume>20</volume> (<issue>6</issue>), <fpage>915</fpage>&#x02013;<lpage>922</lpage>. <pub-id pub-id-type="doi">10.1016/j.tiv.2006.01.016</pub-id>
<pub-id pub-id-type="pmid">16524694</pub-id>
</mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>K.</given-names></name><name><surname>Fan</surname><given-names>M.</given-names></name></person-group> (<year>2025</year>). <article-title>Effects of BMSC-exosomes on the proliferation and migration of chondrocytes</article-title>. <source>J. Med. Biol. Eng.</source>
<volume>45</volume>, <fpage>47</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1007/s40846-025-00926-7</pub-id>
</mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tayebi</surname><given-names>B.</given-names></name><name><surname>Babaahmadi</surname><given-names>M.</given-names></name><name><surname>Pakzad</surname><given-names>M.</given-names></name><name><surname>Hajinasrollah</surname><given-names>M.</given-names></name><name><surname>Mostafaei</surname><given-names>F.</given-names></name><name><surname>Jahangiri</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Standard toxicity study of clinical-grade allogeneic human bone marrow-derived clonal mesenchymal stromal cells</article-title>. <source>Stem Cell Res. Ther.</source>
<volume>13</volume> (<issue>1</issue>), <fpage>213</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-022-02899-9</pub-id>
<pub-id pub-id-type="pmid">35619148</pub-id>
</mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thiruvenkataramani</surname><given-names>R. P.</given-names></name><name><surname>Abdul-Hafez</surname><given-names>A.</given-names></name><name><surname>Kesaraju</surname><given-names>T.</given-names></name><name><surname>Mohamed</surname><given-names>H.</given-names></name><name><surname>Ibrahim</surname><given-names>S. A.</given-names></name><name><surname>Othman</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Small extracellular vesicles derived from cord blood plasma and placental mesenchymal stem cells attenuate acute lung injury induced by lipopolysaccharide (LPS)</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>26</volume> (<issue>1</issue>), <fpage>75</fpage>. <pub-id pub-id-type="doi">10.3390/ijms26010075</pub-id>
<pub-id pub-id-type="pmid">39795932</pub-id>
</mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tian</surname><given-names>Z.</given-names></name><name><surname>Yu</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Higuchi</surname><given-names>A.</given-names></name></person-group> (<year>2023</year>). <article-title>Introduction to stem cells</article-title>. <source>Prog. Mol. Biol. Transl. Sci.</source>
<volume>199</volume>, <fpage>3</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/bs.pmbts.2023.02.012</pub-id>
<pub-id pub-id-type="pmid">37678976</pub-id>
</mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trivanovi&#x00107;</surname><given-names>D.</given-names></name><name><surname>Jaukovi&#x00107;</surname><given-names>A.</given-names></name><name><surname>Popovi&#x00107;</surname><given-names>B.</given-names></name><name><surname>Krsti&#x00107;</surname><given-names>J.</given-names></name><name><surname>Mojsilovi&#x00107;</surname><given-names>S.</given-names></name><name><surname>Oki&#x00107;-Djordjevi&#x00107;</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Mesenchymal stem cells of different origin: comparative evaluation of proliferative capacity, telomere length and pluripotency marker expression</article-title>. <source>Life Sci.</source>
<volume>141</volume>, <fpage>61</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2015.09.019</pub-id>
<pub-id pub-id-type="pmid">26408916</pub-id>
</mixed-citation></ref><ref id="B169"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tseng</surname><given-names>P. C.</given-names></name><name><surname>Hou</surname><given-names>S. M.</given-names></name><name><surname>Chen</surname><given-names>R. J.</given-names></name><name><surname>Peng</surname><given-names>H. W.</given-names></name><name><surname>Hsieh</surname><given-names>C. F.</given-names></name><name><surname>Kuo</surname><given-names>M. L.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis[J]</article-title>. <source>J Bone Miner. Res.</source>
<volume>26</volume> (<issue>10</issue>), <fpage>2552</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1002/jbmr.460</pub-id>
<pub-id pub-id-type="pmid">21713995</pub-id>
</mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ullah</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>D. D.</given-names></name><name><surname>Thakor</surname><given-names>A. S.</given-names></name></person-group> (<year>2019</year>). <article-title>Mesenchymal stromal cell homing: mechanisms and strategies for improvement</article-title>. <source>iScience</source>
<volume>15</volume>, <fpage>421</fpage>&#x02013;<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1016/j.isci.2019.05.004</pub-id>
<pub-id pub-id-type="pmid">31121468</pub-id>
</mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Valipour</surname><given-names>B.</given-names></name><name><surname>Simorgh</surname><given-names>S.</given-names></name><name><surname>Mirsalehi</surname><given-names>M.</given-names></name><name><surname>Moradi</surname><given-names>S.</given-names></name><name><surname>Taghizadeh-Hesary</surname><given-names>F.</given-names></name><name><surname>Seidkhani</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Improvement of spatial learning and memory deficits by intranasal administration of human olfactory ecto-mesenchymal stem cells in an Alzheimer's disease rat model</article-title>. <source>Brain Res.</source>
<volume>1828</volume>, <fpage>148764</fpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2024.148764</pub-id>
<pub-id pub-id-type="pmid">38242524</pub-id>
</mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vauzour</surname><given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects</article-title>. <source>Oxid. Med. Cell Longev.</source>
<volume>2012</volume>, <fpage>1</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1155/2012/914273</pub-id>
</mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vizoso</surname><given-names>F. J.</given-names></name><name><surname>Eiro</surname><given-names>N.</given-names></name><name><surname>Cid</surname><given-names>S.</given-names></name><name><surname>Schneider</surname><given-names>J.</given-names></name><name><surname>Perez-Fernandez</surname><given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>18</volume> (<issue>9</issue>), <fpage>1852</fpage>. <pub-id pub-id-type="doi">10.3390/ijms18091852</pub-id>
<pub-id pub-id-type="pmid">28841158</pub-id>
</mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>W.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>N.</given-names></name><name><surname>Luo</surname><given-names>Y. J.</given-names></name></person-group> (<year>2024</year>). <article-title>Traditional Chinese medicine in Alzheimer's disease: from the perspective of GSK-3&#x003b2; and tau hyperphosphorylation</article-title>. <volume>13</volume>, <fpage>100543</fpage>. <pub-id pub-id-type="doi">10.1016/j.prmcm.2024.100543</pub-id>
</mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>N. Y.</given-names></name><name><surname>Lu</surname><given-names>C. J.</given-names></name><name><surname>Chen</surname><given-names>X. H.</given-names></name></person-group> (<year>2005</year>). <article-title>Study on effect of ginsenoside Rg1 in promoting myocardiac vascular endothelial cell regeneration through induction on bone marrow stem cell's migration and differentiation in rabbits of myocardial infarction</article-title>. <source>Zhongguo Zhong Xi Yi Jie He Za Zhi</source>
<volume>25</volume> (<issue>10</issue>), <fpage>916</fpage>&#x02013;<lpage>919</lpage>.<pub-id pub-id-type="pmid">16313117</pub-id>
</mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Shen</surname><given-names>Z.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Hou</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Astragaloside IV promotes the angiogenic capacity of adipose-derived mesenchymal stem cells in a hindlimb ischemia model by FAK phosphorylation via CXCR2</article-title>. <source>Phytomedicine</source>
<volume>96</volume>, <fpage>153908</fpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2021.153908</pub-id>
<pub-id pub-id-type="pmid">35026516</pub-id>
</mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Ma</surname><given-names>S.</given-names></name><name><surname>Meng</surname><given-names>N.</given-names></name><name><surname>Yao</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Resveratrol exerts dosage-dependent effects on the self-renewal and neural differentiation of hUC-MSCs</article-title>. <source>Mol. Cells</source>
<volume>39</volume> (<issue>5</issue>), <fpage>418</fpage>&#x02013;<lpage>425</lpage>. <pub-id pub-id-type="doi">10.14348/molcells.2016.2345</pub-id>
<pub-id pub-id-type="pmid">27109421</pub-id>
</mixed-citation></ref><ref id="B167"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>C. C.</given-names></name><name><surname>Wang</surname><given-names>C. H.</given-names></name><name><surname>Chen</surname><given-names>H. C.</given-names></name><name><surname>Cherng</surname><given-names>J. H.</given-names></name><name><surname>Chang</surname><given-names>S. J.</given-names></name><name><surname>Wang,</surname><given-names>Y. W.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Combination of resveratrol-containing collagen with adipose stem cells for craniofacial tissue-engineering applications[J]</article-title>. <source>Int. Wound. J.</source>
<volume>15</volume> (<issue>4</issue>), <fpage>660</fpage>&#x02013;<lpage>672</lpage>. <pub-id pub-id-type="doi">10.1111/iwj.12910</pub-id>
<pub-id pub-id-type="pmid">29536622</pub-id>
</mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Wan</surname><given-names>D.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name></person-group> (<year>2019</year>). <article-title>Current situation of injury and its influencing factors among pupils and middle school students in Yanqing district, Beijing, 2017</article-title>. <source>Pract. Prev. Med.</source> (<issue>10</issue>), <fpage>4</fpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1006-3110.2019.10.011</pub-id>
</mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Jiang</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Xiang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Ginsenoside Rg1 improves differentiation by inhibiting senescence of human bone marrow mesenchymal stem cell via GSK-3&#x003b2; and &#x003b2;-catenin</article-title>. <source>Stem Cells Int.</source>
<volume>2020</volume>, <fpage>1</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1155/2020/2365814</pub-id>
</mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Jiang</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Xiao</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Ginsenoside Rg1 prevents bone marrow mesenchymal stem cell senescence via NRF2 and PI3K/Akt signaling</article-title>. <source>Free Radic. Biol. Med.</source>
<volume>174</volume>, <fpage>182</fpage>&#x02013;<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2021.08.007</pub-id>
<pub-id pub-id-type="pmid">34364981</pub-id>
</mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>A. C.</given-names></name><name><surname>Igarashi</surname><given-names>K. J.</given-names></name><name><surname>Nakauchi</surname><given-names>H.</given-names></name></person-group> (<year>2020</year>). <article-title>Haematopoietic stem cell self-renewal <italic>in vivo</italic> and <italic>ex vivo</italic>
</article-title>. <source>Nat. Rev. Genet.</source>
<volume>21</volume> (<issue>9</issue>), <fpage>541</fpage>&#x02013;<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1038/s41576-020-0241-0</pub-id>
<pub-id pub-id-type="pmid">32467607</pub-id>
</mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Ge</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>N.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name></person-group> (<year>2024</year>). <article-title>Neuroprotective effect of tanshinone IIA-modified mesenchymal stem cells in a lipopolysaccharide-induced neuroinflammation model</article-title>. <source>Heliyon</source>
<volume>10</volume> (<issue>8</issue>), <fpage>e29424</fpage>. <pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e29424</pub-id>
<pub-id pub-id-type="pmid">38638958</pub-id>
</mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>J. J.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Wan</surname><given-names>Y.</given-names></name><name><surname>Xia</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>J. F.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer's disease</article-title>. <source>Biomed. Pharmacother.</source>
<volume>152</volume>, <fpage>113207</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2022.113207</pub-id>
<pub-id pub-id-type="pmid">35667236</pub-id>
</mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>T.</given-names></name><name><surname>Shu</surname><given-names>T.</given-names></name><name><surname>Kang</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Xing</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Icaritin, a novel plant-derived osteoinductive agent, enhances the osteogenic differentiation of human bone marrow- and human adipose tissue-derived mesenchymal stem cells</article-title>. <source>Int. J. Mol. Med.</source>
<volume>39</volume> (<issue>4</issue>), <fpage>984</fpage>&#x02013;<lpage>992</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2017.2906</pub-id>
<pub-id pub-id-type="pmid">28260001</pub-id>
</mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xie</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Song</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Tanshinone IIA and astragaloside IV promote the migration of mesenchymal stem cells by up-regulation of CXCR4</article-title>. <source>Protoplasma</source>
<volume>250</volume> (<issue>2</issue>), <fpage>521</fpage>&#x02013;<lpage>530</lpage>. <pub-id pub-id-type="doi">10.1007/s00709-012-0435-1</pub-id>
<pub-id pub-id-type="pmid">22872094</pub-id>
</mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xie</surname><given-names>L.</given-names></name><name><surname>Zhu</surname><given-names>Q.</given-names></name><name><surname>Lu</surname><given-names>J. J. C.</given-names></name></person-group> (<year>2022</year>). <article-title>Can we use Ginkgo biloba extract to treat Alzheimer&#x02019;s disease? Lessons from preclinical and clinical studies</article-title>. <source>Cells</source>
<volume>11</volume> (<issue>3</issue>), <fpage>479</fpage>. <pub-id pub-id-type="doi">10.3390/cells11030479</pub-id>
<pub-id pub-id-type="pmid">35159288</pub-id>
</mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>A.</given-names></name><name><surname>Yu</surname><given-names>C.</given-names></name><name><surname>Lu</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>He</surname><given-names>C.</given-names></name></person-group> (<year>2019</year>). <article-title>Mechanism of action of icariin in bone marrow mesenchymal stem cells</article-title>. <source>Stem Cells Int.</source>
<volume>2019</volume>, <fpage>1</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1155/2019/5747298</pub-id>
</mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>C.</given-names></name><name><surname>Zeng</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>B.</given-names></name></person-group> (<year>2025</year>). <article-title>hsa_circ_0001599 promotes odontogenic differentiation of human dental pulp stem cells by increasing ITGA2 expression and stability</article-title>. <source>Commun. Biol.</source>
<volume>8</volume> (<issue>1</issue>), <fpage>74</fpage>. <pub-id pub-id-type="doi">10.1038/s42003-025-07488-z</pub-id>
<pub-id pub-id-type="pmid">39825107</pub-id>
</mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.-H. K.</given-names></name><name><surname>Ogando</surname><given-names>C. R.</given-names></name><name><surname>Wang See</surname><given-names>C.</given-names></name><name><surname>Chang</surname><given-names>T.-Y.</given-names></name><name><surname>Barabino</surname><given-names>G. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Changes in phenotype and differentiation potential of human mesenchymal stem cells aging <italic>in vitro</italic>
</article-title>. <source>Stem Cell Res. Ther.</source>
<volume>9</volume> (<issue>1</issue>), <fpage>131</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-018-0876-3</pub-id>
<pub-id pub-id-type="pmid">29751774</pub-id>
</mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yaylac&#x00131;</surname><given-names>S.</given-names></name><name><surname>Ka&#x000e7;aro&#x0011f;lu</surname><given-names>D.</given-names></name><name><surname>H&#x000fc;rkal</surname><given-names>&#x000d6;.</given-names></name><name><surname>Ula&#x0015f;l&#x00131;</surname><given-names>A. M.</given-names></name></person-group> (<year>2023</year>). <article-title>An enzyme-free technique enables the isolation of a large number of adipose-derived stem cells at the bedside</article-title>. <source>Sci. Rep.</source>
<volume>13</volume> (<issue>1</issue>), <fpage>8005</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-023-34915-0</pub-id>
<pub-id pub-id-type="pmid">37198228</pub-id>
</mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ye</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Xiao</surname><given-names>H.</given-names></name><name><surname>Tan</surname><given-names>Q.</given-names></name><name><surname>Yan</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>METTL3 promotes the osteogenic differentiation of periosteum-derived MSCs via regulation of the HOXD8/ITGA5 axis in congenital pseudarthrosis</article-title>. <source>Regen. Ther.</source>
<volume>26</volume>, <fpage>42</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.reth.2024.04.004</pub-id>
<pub-id pub-id-type="pmid">38818480</pub-id>
</mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yoon</surname><given-names>D. S.</given-names></name><name><surname>Choi</surname><given-names>Y.</given-names></name><name><surname>Choi</surname><given-names>S. M.</given-names></name><name><surname>Park</surname><given-names>K. H.</given-names></name><name><surname>Lee</surname><given-names>J. W.</given-names></name></person-group> (<year>2015</year>). <article-title>Different effects of resveratrol on early and late passage mesenchymal stem cells through &#x003b2;-catenin regulation</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>467</volume> (<issue>4</issue>), <fpage>1026</fpage>&#x02013;<lpage>1032</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2015.10.017</pub-id>
<pub-id pub-id-type="pmid">26456654</pub-id>
</mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Young</surname><given-names>T. Z.</given-names></name><name><surname>Liu</surname><given-names>P.</given-names></name><name><surname>Urbonaite</surname><given-names>G.</given-names></name><name><surname>Acar</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Quantitative insights into age-associated DNA-repair inefficiency in single cells</article-title>. <source>Cell Rep.</source>
<volume>28</volume> (<issue>8</issue>), <fpage>2220</fpage>&#x02013;<lpage>2230.e7</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2019.07.082</pub-id>
<pub-id pub-id-type="pmid">31433994</pub-id>
</mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Liao</surname><given-names>N.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name></person-group> (<year>2023</year>). <article-title>Enhancing mesenchymal stem cell survival and homing capability to improve cell engraftment efficacy for liver diseases</article-title>. <source>Stem Cell Res. Ther.</source>
<volume>14</volume> (<issue>1</issue>), <fpage>235</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-023-03476-4</pub-id>
<pub-id pub-id-type="pmid">37667383</pub-id>
</mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>W.</given-names></name><name><surname>Lv</surname><given-names>Y.</given-names></name><name><surname>Xuan</surname><given-names>R.</given-names></name><name><surname>Han</surname><given-names>P.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name></person-group> (<year>2024</year>). <article-title>Human placental mesenchymal stem cells transplantation repairs the alveolar epithelial barrier to alleviate lipopolysaccharides-induced acute lung injury</article-title>. <source>Biochem. Pharmacol.</source>
<volume>229</volume>, <fpage>116547</fpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2024.116547</pub-id>
<pub-id pub-id-type="pmid">39306309</pub-id>
</mixed-citation></ref><ref id="B168"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yuan</surname><given-names>P.</given-names></name><name><surname>Qin</surname><given-names>H. Y.</given-names></name><name><surname>Wei</surname><given-names>J.Y.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name></person-group> (<year>2022</year>). <article-title>Proteomics reveals the potential mechanism of Tanshinone IIA in promoting the Ex Vivo expansion of human bone marrow mesenchymal stem cells[J]</article-title>. <source>Regen Ther.</source>
<volume>21</volume>, <fpage>560</fpage>&#x02013;<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1016/j.reth.2022.11.004</pub-id>
<pub-id pub-id-type="pmid">36475023</pub-id>
</mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yun</surname><given-names>W. S.</given-names></name><name><surname>Cho</surname><given-names>H.</given-names></name><name><surname>Jeon</surname><given-names>S. I.</given-names></name><name><surname>Lim</surname><given-names>D.-K.</given-names></name><name><surname>Kim</surname><given-names>K. J. B.</given-names></name></person-group> (<year>2023</year>). <article-title>Fluorescence-based mono- and multimodal imaging for <italic>in vivo</italic> tracking of mesenchymal stem cells</article-title>. <source>Stem Cells</source>
<volume>13</volume> (<issue>12</issue>), <fpage>1787</fpage>. <pub-id pub-id-type="doi">10.3390/biom13121787</pub-id>
</mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yun</surname><given-names>Y. C.</given-names></name><name><surname>Jeong</surname><given-names>S. G.</given-names></name><name><surname>Kim</surname><given-names>S. H.</given-names></name><name><surname>Cho</surname><given-names>G. W.</given-names></name></person-group> (<year>2019</year>). <article-title>Reduced sirtuin 1/adenosine monophosphate-activated protein kinase in amyotrophic lateral sclerosis patient-derived mesenchymal stem cells can be restored by resveratrol</article-title>. <source>J. Tissue Eng. Regen. Med.</source>
<volume>13</volume> (<issue>1</issue>), <fpage>110</fpage>&#x02013;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1002/term.2776</pub-id>
<pub-id pub-id-type="pmid">30479062</pub-id>
</mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zeng</surname><given-names>N.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name></person-group> (<year>2022</year>). <article-title>Adipose stem cell-based treatments for wound healing</article-title>, <source>Front. Cell Dev. Biol.</source>, <volume>9</volume>. <fpage>821652</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2021.821652</pub-id>
<pub-id pub-id-type="pmid">35087840</pub-id>
</mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zeng</surname><given-names>X.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Su</surname><given-names>W.</given-names></name></person-group> (<year>2021</year>). <article-title>Chemical composition, quality control, pharmacokinetics, pharmacological properties and clinical applications of Fufang Danshen Tablet: a systematic review</article-title>. <source>J. Ethnopharmacol.</source>
<volume>278</volume>, <fpage>114310</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2021.114310</pub-id>
<pub-id pub-id-type="pmid">34107328</pub-id>
</mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Gao</surname><given-names>L.</given-names></name><name><surname>Du</surname><given-names>G.</given-names></name><name><surname>Qin</surname><given-names>X.</given-names></name></person-group> (<year>2020</year>). <article-title>Astragaloside IV derived from Astragalus membranaceus: a research review on the pharmacological effects</article-title>. <source>Adv. Pharmacol.</source>
<volume>87</volume>, <fpage>89</fpage>&#x02013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/bs.apha.2019.08.002</pub-id>
<pub-id pub-id-type="pmid">32089240</pub-id>
</mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Dong</surname><given-names>J.</given-names></name><name><surname>Fan</surname><given-names>X.</given-names></name><name><surname>Yong</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Characterization of mesenchymal stem cells in human fetal bone marrow by single-cell transcriptomic and functional analysis</article-title>. <source>Signal Transduct. Target Ther.</source>
<volume>8</volume> (<issue>1</issue>), <fpage>126</fpage>. <pub-id pub-id-type="doi">10.1038/s41392-023-01338-2</pub-id>
<pub-id pub-id-type="pmid">36997513</pub-id>
</mixed-citation></ref><ref id="B160"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.-b.</given-names></name><name><surname>Chen</surname><given-names>X.-y.</given-names></name><name><surname>Qi</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>H.-y.</given-names></name><name><surname>Zhao</surname><given-names>X.-b.</given-names></name><name><surname>Hu</surname><given-names>Y.-c.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>New hope for intervertebral disc degeneration: bone marrow MesenchymalStem cells and exosomes derived from bone marrow MesenchymalStem cell transplantation</article-title>. <source>stem cell Transplant.</source>
<volume>22</volume> (<issue>4</issue>), <fpage>291</fpage>&#x02013;<lpage>302</lpage>. <pub-id pub-id-type="doi">10.2174/1566523221666211012092855</pub-id>
</mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X. M.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>B. Q.</given-names></name><name><surname>Jiao</surname><given-names>Z. M.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Tanshinone IIA promotes the differentiation of bone marrow mesenchymal stem cells into neuronal-like cells in a spinal cord injury model</article-title>. <source>J. Transl. Med.</source>
<volume>16</volume> (<issue>1</issue>), <fpage>193</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-018-1571-y</pub-id>
<pub-id pub-id-type="pmid">30001730</pub-id>
</mixed-citation></ref><ref id="B162"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Ravikumar</surname><given-names>M.</given-names></name><name><surname>Ling</surname><given-names>L.</given-names></name><name><surname>Nurcombe</surname><given-names>V.</given-names></name><name><surname>Cool</surname><given-names>S. M.</given-names></name></person-group> (<year>2021</year>). <article-title>Age-related changes in the inflammatory status of human mesenchymal stem cells: implications for cell therapy</article-title>. <source>Stem Cell Rep.</source>
<volume>16</volume> (<issue>4</issue>), <fpage>694</fpage>&#x02013;<lpage>707</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2021.01.021</pub-id>
</mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>P. D.</given-names></name><name><surname>Mungur</surname><given-names>R.</given-names></name><name><surname>Zhou</surname><given-names>H. J.</given-names></name><name><surname>Hassan</surname><given-names>M.</given-names></name><name><surname>Jiang</surname><given-names>S. N.</given-names></name><name><surname>Zheng</surname><given-names>J. S.</given-names></name></person-group> (<year>2018</year>). <article-title>Ginkgolide B promotes the proliferation and differentiation of neural stem cells following cerebral ischemia/reperfusion injury, both <italic>in vivo</italic> and <italic>in vitro</italic>
</article-title>. <source>Neural Regen. Res.</source>
<volume>13</volume> (<issue>7</issue>), <fpage>1204</fpage>&#x02013;<lpage>1211</lpage>. <pub-id pub-id-type="doi">10.4103/1673-5374.232476</pub-id>
<pub-id pub-id-type="pmid">30028328</pub-id>
</mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhidu</surname><given-names>S.</given-names></name><name><surname>Ying</surname><given-names>T.</given-names></name><name><surname>Rui</surname><given-names>J.</given-names></name><name><surname>Chao</surname><given-names>Z.</given-names></name></person-group> (<year>2024</year>). <article-title>Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities</article-title>. <source>Stem Cell Res. Ther.</source>
<volume>15</volume> (<issue>1</issue>), <fpage>266</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-024-03885-z</pub-id>
<pub-id pub-id-type="pmid">39183341</pub-id>
</mixed-citation></ref><ref id="B165"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name></person-group> (<year>2023</year>). <article-title>Mesenchymal stem/stromal cells (MSCs): origin, immune regulation, and clinical applications</article-title>. <source>Cell Mol. Immunol.</source>
<volume>20</volume> (<issue>6</issue>), <fpage>555</fpage>&#x02013;<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1038/s41423-023-01034-9</pub-id>
<pub-id pub-id-type="pmid">37225837</pub-id>
</mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>T.</given-names></name><name><surname>Yuan</surname><given-names>Z.</given-names></name><name><surname>Weng</surname><given-names>J.</given-names></name><name><surname>Pei</surname><given-names>D.</given-names></name><name><surname>Du</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Challenges and advances in clinical applications of mesenchymal stromal cells</article-title>. <source>J. Hematol. Oncol.</source>
<volume>14</volume> (<issue>1</issue>), <fpage>24</fpage>. <pub-id pub-id-type="doi">10.1186/s13045-021-01037-x</pub-id>
<pub-id pub-id-type="pmid">33579329</pub-id>
</mixed-citation></ref></ref-list></back></article>